WO2019054707A1 - Novel triazine derivative and photosensitive composition comprising same - Google Patents

Novel triazine derivative and photosensitive composition comprising same Download PDF

Info

Publication number
WO2019054707A1
WO2019054707A1 PCT/KR2018/010549 KR2018010549W WO2019054707A1 WO 2019054707 A1 WO2019054707 A1 WO 2019054707A1 KR 2018010549 W KR2018010549 W KR 2018010549W WO 2019054707 A1 WO2019054707 A1 WO 2019054707A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
group
substituted
unsubstituted
formula
Prior art date
Application number
PCT/KR2018/010549
Other languages
French (fr)
Korean (ko)
Inventor
이규성
문봉석
진성민
강지승
하민수
진상준
박노길
이현우
변우근
Original Assignee
주식회사 트리엘
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180107042A external-priority patent/KR102145580B1/en
Application filed by 주식회사 트리엘 filed Critical 주식회사 트리엘
Priority to CN201880057939.8A priority Critical patent/CN111065628B/en
Priority to JP2020535948A priority patent/JP6965455B2/en
Priority to US16/643,250 priority patent/US11427551B2/en
Publication of WO2019054707A1 publication Critical patent/WO2019054707A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/54Three nitrogen atoms
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/028Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators

Definitions

  • the present invention relates to a novel triazine derivative and a photosensitive composition containing the same, and more particularly to a novel triazine derivative having a high refractive index after a photo-crosslinking process, excellent curability in a process of producing an optical material, A novel triazine derivative having excellent properties and a photosensitive composition containing the novel triazine derivative.
  • a liquid crystal display includes an optical sheet including an optical pattern formed on a base film and a base film, and a light guide plate is disposed under the optical sheet, or another optical sheet is provided between the optical sheet and the light guide plate .
  • optical sheets include a reflector sheet, a diffuser sheet, a prism sheet, These optical sheets are used for the purpose of improving the brightness of the backlight unit.
  • the optical sheet increases the brightness of light emitted in such a manner that light emitted from the light guide plate of the backlight is refracted and transmitted to the screen after passing through the liquid crystal.
  • the refractive index of the optical sheet such as prism and DBEF It should be high.
  • the conventional high-refraction monomers have a low refractive index and thus have limitations in realizing brightness enhancement effects. Further, even when the refractive index of the optical sheet is increased, yellowing occurs in the optical sheet.
  • Korean Patent Registration No. 10-1692343 2016.12.28
  • Korean Patent Laid-Open Publication No. 10-2017-0013674 2017.02.07 propose an acrylic monomer as a high refractive index monomer have.
  • a first technical object of the present invention is to provide a novel triazine derivative compound which has high transmittance, excellent light-crosslinking property and yellowing resistance, and which can be used as a monomer in a photosensitive composition having high refractive index .
  • a second technical object of the present invention is to provide a photosensitive composition comprising the triazine derivative compound and an optical article obtained by polymerizing the same.
  • the present invention provides a compound represented by any one of the following formulas (A) to (C).
  • Ra is any substituent selected from hydrogen, deuterium, substituted or unsubstituted C 1 -C 6 alkyl group,
  • L1 is a single bond, O, S, or -N (-R5) -,
  • L2 is a single bond, O, S, or -N (-R6) -,
  • X 1 to X 3 are the same or different and independently of each other are a single bond, O, S, -N (-R 7) - or -O ((CH 2 ) m O) n - n is an integer selected from 1 to 4, and at least two of X1 to X3 each represent -N (-R7) -, or two or more of X1 to X3 each independently represent - O ((CH 2) m O ) n - each -N (-R7) in the case of selecting - and -O ((CH 2) m O ) n - may be identical to or different from each other, and
  • R4 to R7 are the same or different, independently represent hydrogen, deuterium, substituted or unsubstituted C 1 -C 30 an alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted C 6 -C 50 ring, each ring of A C 3 -C 30 cycloalkyl group, and a substituted or unsubstituted C 7 -C 24 arylalkyl group,
  • W1 is any one selected from an alkylene group of a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, a substituted or unsubstituted C 1 -C 12 a,
  • W2 and W3 are the same or different and each independently represent a single bond, a substituted or unsubstituted C 1 a C 6 aryl group, a substituted or unsubstituted ring of -C 30 alkylene group, a substituted or unsubstituted -C 30 unsubstituted C 2 -C 30 of alkenylene group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group, the substituted or unsubstituted C 2 -C 50 hetero arylene group, and any one is selected from a substituted or unsubstituted heterocycloalkyl group of C 2 -C 30 a,
  • Y1 and Y2 are the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or non-substituted of unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 of each ring C, respectively of 2 -C 30 alkenyl group, a substituted or unsubstituted C 2 -C 20 alkynyl of the group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group , A substituted or unsubstituted C 2 -C 50 heteroaryl group, a substituted or unsubstituted C 2 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 1 -C 30 alkylsilyl group, a
  • Rb and Rc are each the same or different, and independently are any one selected from the group consisting of hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6 with each other,
  • Ar 1 is a substituted or unsubstituted C 6 -C 30 arylene group, a substituted or unsubstituted C 2 -C 30 heteroarylene group, a substituted or unsubstituted C 1 -C 30 alkylene group, and the one which is C 2 -C 30 alkenylene group, selected from substituted or unsubstituted C 3 -C 30 cycloalkylene group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group of the,
  • L6 is any one selected from a single bond, O, S, -N (-R11) -,
  • L7 is any of a single bond, O, S, -N (-R12) -,
  • Rd is a substituent of any one selected from hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6,
  • Each of L3 to L5 is the same or different and independently selected from a single bond, O, S, or -N (-R9) -,
  • each of -N (-R9) is the same or different
  • X4 to X7 are the same or different and each, independently of one another a single bond, O, S, -N (-R10 ) -, -O ((CH 2) m O) n - are optionally replaced with one selected from said m and n are the same or different and are each independently an integer selected from 1 to 4,
  • R8 to R12 are the same or different, independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or unsubstituted of C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 ring, each ring of the A C 3 -C 30 cycloalkyl group, and a substituted or unsubstituted C 7 -C 24 arylalkyl group,
  • W4 is any one selected from the group consisting of a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, and a substituted or unsubstituted C 1 -C 12 alkylene group,
  • the W5 to W7 are the same or different and each independently represent a single bond, a substituted or unsubstituted C 1 -C 30 an alkyl group, an arylene group, a substituted or unsubstituted substituted or unsubstituted C 6 -C 30 unsubstituted C 2 -C 30 of alkenylene group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group, the substituted or unsubstituted C 2 -C 50 hetero arylene group, and any one is selected from a substituted or unsubstituted heterocycloalkyl group of C 2 -C 30 a,
  • the Y3 to Y5 are the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or non-substituted of unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 of each ring C, respectively of 2 -C 30 alkenyl group, a substituted or unsubstituted C 2 -C 20 alkynyl of the group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group , A substituted or unsubstituted C 2 -C 50 heteroaryl group, a substituted or unsubstituted C 2 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 1 -C 30 alkylsilyl group, a
  • Rb and Rc are each the same or different, and independently are any one selected from the group consisting of hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6 with each other,
  • the present invention also provides a photosensitive composition
  • a photosensitive composition comprising a compound represented by any one of the above-mentioned formulas (A) to (C) and an optical material or an optical article obtained by polymerizing the same.
  • novel triazine derivative compounds represented by any one of the formulas (A) to (C) according to the present invention can be used in a photosensitive composition to provide a property of high refractive index after the photo-crosslinking step.
  • a photosensitive composition having a high transmittance and an excellent yellowing resistance characteristic, and has a limit in realizing a luminance improvement effect due to a low refractive index according to the prior art, and can solve the problem of color change of the optical sheet due to yellowing (DBEF) film, a coating material for an organic light emitting device (OLED), an optical lens, and a multifocal lens, which can be applied to a prism sheet, a microlens, a coating material for an LCD, a DBEF (Dual Brightness Enhancement Film)
  • DBEF Yellowing
  • the compound represented by any one of the above-mentioned formulas (A) to (C) according to the present invention contains 1 to 3 triazine structures and may contain N, O, S or a single bond to each carbon atom of the triazine A first connecting portion; A second connecting portion comprising a single bond, an alkylene group or an arylene group; And a third connecting portion having N, O, S, alkylene oxide, or a single bond, and having a double bond such as at least one acrylic acid derivative at the terminal, wherein, among three carbon atoms of triazine,
  • a technical feature is that a nitrogen atom is bonded to at least one carbon atom and a terminal thereof has a double bond such as an acrylic acid derivative.
  • the carbon numbers of the C 1 -C 20 alkyl group and the C 6 -C 50 aryl group are each an alkyl moiety or an aryl moiety constituting the alkyl moiety or the aryl moiety when considered to be unsubstituted, Means the number of carbon atoms.
  • a phenyl group substituted with a butyl group at the para position should be considered to correspond to a C 6 aryl group substituted with a C 4 butyl group.
  • the aryl group which is a substituent used in the compound of the present invention is an organic radical derived from an aromatic hydrocarbon by one hydrogen elimination and includes a single or fused ring system containing 5 to 7 atoms, preferably 5 or 6 atoms, When a substituent is present in the aryl group, the adjacent substituent may be fused with each other to form a ring.
  • the heteroaryl group which is a substituent used in the compound of the present invention is a heteroaryl group having 1, 2 or 3 hetero atoms selected from N, O, P, Si, S, Ge, Se and Te in the aryl group, Means a C 2 -C 24 ring aromatic system, which rings can be fused to form a ring. And at least one hydrogen atom of the heteroaryl group may be substituted with the same substituent as the aryl group.
  • alkyl group as a substituent used in the present invention examples include methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, iso-amyl and hexyl.
  • the hydrogen atoms of the above hydrogen atoms can be substituted with the same substituents as those in the aryl group.
  • alkoxy group used as the substituent in the compound of the present invention include methoxy, ethoxy, propoxy, isobutyloxy, sec-butyloxy, pentyloxy, iso-amyloxy, hexyloxy, At least one hydrogen atom in the alkoxy group may be substituted with the same substituent as in the case of the aryl group.
  • alkylaryl group used as the substituent in the compound of the present invention include methylphenyl, dimethylphenyl, n -propylphenyl, t -butylphenyl, methylnaphthyl and the like, May be substituted with the same substituents as those in the aryl group.
  • the above hydrogen atoms may be substituted with substituents similar to those in the aryl group.
  • silyl group used as the substituent in the compound of the present invention include trimethylsilyl, triethylsilyl, triphenylsilyl, trimethoxysilyl, dimethoxyphenylsilyl, diphenylmethylsilyl, diphenylvinylsilyl, methylcyclobutylsilyl , And dimethylpurylsilyl.
  • At least one hydrogen atom of the silyl group may be substituted with the same substituent as the aryl group.
  • R6 is preferably the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted C 1 -C 20 alkyl group, a substituted or unsubstituted C of each other, respectively And an aryl group having 6 to 20 carbon atoms, and Ra, Rb and Rc are preferably the same or different, and independently of each other may be any substituent selected from hydrogen and a deuterated methyl group.
  • At least one of Y1 and Y2 in formula (A) may be a structural formula (1) or a structural formula (2).
  • L 1 in the formula (A) may be -N (-R 5) - or S
  • L 2 may be -N (-R 6) - or S, more preferably L 1 is -N (-R 5)
  • L2 is a -N (-R6) -
  • R5 and R6 are either same or different and are each, independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 of Lt; / RTI >
  • L 1 and L 2 may each contain a nitrogen atom or a sulfur atom, and when they contain a nitrogen atom or a sulfur atom, they are more preferable since they have a high transparency and a high refractive index.
  • At least one of the formula (A) in W1 to W3 in the present invention is substituted or unsubstituted C 6 arylene group may be the date -C 30 ring, preferably, W1 to two are a substituted or unsubstituted C of W3 6 or an aryl group of 30 or -C W1 to W3 can all arylene date of substituted or unsubstituted C 6 -C 30.
  • the plate structure is formed due to the aromatic plane structure of the C 6 -C 30 arylene group and the plane structure of the triazine, and thus high high-refraction characteristics can be obtained.
  • At least one of the formula (A) in W1 to W3 is a substituted or Examples of the unsubstituted aryl group of C 6 -C 30, wherein the formula (A) in W1 is a substituted or unsubstituted phenylene group ring, wherein W2 and W3 May be the same or different and independently of each other, a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, or a substituted or unsubstituted C 1 -C 12 alkylene group.
  • W 1 is a substituted or unsubstituted phenylene group
  • W 2 and W 3 are the same At least one of them is a substituted or unsubstituted C 6 -C 30 arylene group
  • W 1 to W 3 are the same or different, and at least two of them are a substituted or unsubstituted phenylene group
  • W1 to W3 are the same or different and each is a substituted or unsubstituted phenylene group.
  • the above-mentioned [Chemical Formula B] and [Chemical Formula C] within substituents R8 to R12 are preferably identical or different and, independently from each other hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 20 respectively according to the present invention , substituted or unsubstituted and which is selected from aryl groups unsubstituted C 6 -C 20 a, Ra, Rb and Rc is preferably any of the substituents, the same or different and independently selected from hydrogen, deuterium, a methyl group from each other, respectively Lt; / RTI >
  • At least one of Y 3 and Y 5 in the above formulas (B) and (C) may be a structural formula 1 or a structural formula 2. By having such a structure, both ends of the monomer have a double bond, Can be adjusted.
  • L 3 to L 7 are the same or different and independently of each other, a single bond, -N (-R 9) - or S, and two or more of L 3 to L 7 are each -N ) each in the case of selecting -N (-R9) - are either the same or different, independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 of Lt; / RTI >
  • L3 to L5 are the same or different and independently of each other, a single bond, -N (-R9) - or S, and two or more of L3 to L5 are each -N ) each in the case of selecting -N (-R9) - are either the same or different, independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 of Lt; / RTI >
  • L3 to L7 in the above formulas (B) and (C) may contain a nitrogen atom or a sulfur atom, and when they contain a nitrogen atom or a sulfur atom, they have a high transparency and a high refractive index, Do.
  • the one selected from Formula B] and [Chemical Formula C] within R9, R11 to R12 are the same or different and each independently represent hydrogen, deuterium, aryl group of C 1 -C 10 alkyl, C 6 -C 20 of each other It can be one.
  • the plate structure is formed due to the aromatic plane structure of the C 6 -C 30 arylene group and the plane structure of the triazine, and thus high high-refraction characteristics can be obtained.
  • the W4 to the remaining one or two phenylene groups, not of W7 are the same or different and independently of each other a single bond, an arylene group, a substituted or unsubstituted substituted or unsubstituted C 6 -C 30 ring And may be a C 1 -C 12 alkylene group.
  • W4 to W7 in the above formulas (B) and (C) are substituted or unsubstituted C 6 -C 30 arylene groups, And all or four of them may be a substituted or unsubstituted phenylene group.
  • the W4 through W7 3 dogs substituted or unsubstituted on the remaining unsubstituted phenylene group is not phenylene group one is a single bond, a substituted or unsubstituted C 6 -C 30 aryl group, a substituted or unsubstituted C of Or an alkylene group of 1 to 12 carbon atoms.
  • the present invention provides a photosensitive composition
  • a photosensitive composition comprising a compound represented by any one of the above-mentioned formulas (A) to (C).
  • the compound represented by any one of the above-mentioned formulas (A) to (C) according to the present invention may be contained in the photoreactive composition as a photocrosslinkable monomer to form a thin film or a prism by light such as UV,
  • the composition When the composition is used in a composition for a display or an electronic material, it has an excellent compatibility with a solvent or an acrylic monomer.
  • the compounds represented by any one of the above-mentioned formulas (A) to (C) are excellent in refractive index, transmittance and yellowing resistance and can improve brightness and performance when used as a high refractive index monomer for TFT-LCD and OLED.
  • the photosensitive composition may further include a photoinitiator or a photopolymerizable monomer, and may include, but not limited to, a substance used in other known photosensitive compositions.
  • the present invention also provides an optical article obtained by polymerizing the photosensitive composition.
  • the photosensitive composition of the present invention 1 to 95 parts by weight of a compound represented by any one of the above formulas (A) to (C), 0 to 90 parts by weight of a photopolymerizable compound and 0.1 to 20 parts by weight of a photoinitiator.
  • the photopolymerizable compound means a compound containing one or two or more acryl groups, methacrylic groups or vinyl groups
  • the photoinitiator according to the present invention is a compound which is formed by radicals generated by UV and crosslinked by the generated radicals.
  • the photopolymerizable compound may be an alkyl acrylate such as hexyl (meth) acrylate, cyclohexyl (meth) acrylate, tetradecyl (meth) acrylate and hexadecyl (meth) acrylate; (Meth) acrylate, pentaerythritol tetra (meth) acrylate, pentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, (Meth) acrylate, trimethylol propane di (meth) acrylate, trimethylol propane tri (meth) acrylate, pentaerythritol tri (meth) acrylate, acrylic acid, methacrylic acid, glycidyl acrylate, .
  • alkyl acrylate such as hexyl (meth) acrylate, cyclohexyl (
  • photoinitiator examples include ketones, ketoacetals, thioguanthones, phosphine oxides, anthraquinones, trichloromethyl triazine, and oxime esters.
  • photo initiators include phenylbiphenyl ketone, 1-benzyl-1-dimethylamino-1- (4-morpholino-benzoyl) propane, 1-hydroxy-1-benzoylcyclopentane, Benzoyl-4-methylphenyl sulfide, benzoin butyl ether, 2-hydroxy-2-benzoyl propane, 2-methyl- Butylbenzoyl trichloromethane, 4-phenoxybenzoyl dichloromethane, diphenyl-2,4,6-trimethylbenzoylphosphine oxide, methyl benzoylformate, methyl benzoate, (Trichloromethyl) -s-triazine, 2-methyl-4,6-bis (trichloromethyl) Na
  • Such a photoinitiator is more preferably used in an amount of 0.1 to 20 parts by weight, preferably 0.1 to 10 parts by weight, based on 100 parts by weight of the photosensitive composition, in order to control exposure sensitivity and pattern characteristics.
  • an organic solvent may optionally be used to dissolve the photosensitive composition, Is used for improving the coating property, and it is preferable to use an organic solvent as such solvent.
  • organic solvent preferably ethyl acetate, butyl acetate, diethylene glycol dimethyl ether, diethylene glycol dimethyl ethyl ether, methyl methoxy propionate, ethyl ethoxypropionate (EEP), ethyl lactate, propylene glycol Methyl ether acetate (PGMEA), propylene glycol methyl ether, propylene glycol propyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol methyl acetate, diethylene glycol ethyl acetate, acetone, methyl isobutyl ketone, (NMP), gamma -butyrolactone, diethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol dimethyl ether
  • the reaction conditions are as follows: Diglyme, tetrahydrofuran (THF), methanol,
  • the photosensitive composition according to the present invention can be used for producing any one selected from a prism sheet, a microlens, a coating material for LCD, a DBEF film, a coating material for an organic light emitting diode (OLED) have.
  • the reaction scheme 1 shows a synthetic mechanism for a part of the compounds having an acryl group and may be appropriately substituted with a substituent such that the substituent is appropriately substituted with a substituent selected from the group consisting of a variety of acrylic groups represented by any one of the formulas (A), (B) Compounds can be synthesized.
  • reaction vessel 150 mL of THF is added to a 500 mL reactor, and 15.0 g (81.3 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.0 g (81.3 mmol) of 2-aminoethanol and 12.7 g (162.6 mmol) of 2-mercaptoethanol were slowly added in succession for 30 min each time with stirring, and 20.0 g (243.9 mmol) . The reaction vessel is heated to 80 ° C and stirred for 15 hours. After the completion of the reaction, distilled water and ethyl acetate are added and removed.
  • a 250 ml reactor was charged with 100 ml of THF, 20 ml of triethylamine and 10.0 g of 2,2 '- ((6 - ((2-hydroxyethyl) thio) -1,3,5-triazine-2,4-diyl) bis (methylazanediyl) 32.9 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 10.3 g (98.8 mmol) of methacryloyl chloride was slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 10 hours.
  • Diacetyl) diphenol 23.0 g of 3,3 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine- (Yield: 73%).
  • Example 1 and Example 2 the high-refraction monomers were prepared by using the following R1 (((9H-fluorene-9,9-diyl) bis (4,1- phenylene)) bis (Ethane-2, 1 -dine) diacrylate.
  • the synthesized high-refractive-index acrylic monomer was dissolved in the same weight ratio to 2 - ([1,1'-biphenyl] -2-yloxy) ethyl acrylate and then measured by ABBE refractometer at 25 ° C.
  • the high-refractive-index acrylic monomers thus synthesized were dissolved in the same weight ratio to 2 - ([1,1'-biphenyl] -2-yloxy) ethyl acrylate, and the viscosity was measured with a Brookfield viscometer at 25 ° C.
  • a crosslinked prism sheet specimen was prepared by UV irradiation at 500 mJ / cm 2 on an optical PET substrate.
  • the crosslinked prism sheet was measured for UV transmittance at 400 nm using a UV-vis.
  • the crosslinked prism sheet was subjected to a UVA lamp 1J for 8 hours at 95 ° C for 8 hours at 60 ° C using a reliability evaluation system (QUV tester) for 120 hours and then the value of change ⁇ YI Respectively.
  • QUV tester a reliability evaluation system
  • the photosensitive compositions of Examples 1 to 16 of the present invention exhibited remarkably high refractive index and similar viscosities to those of the compositions of Comparative Examples 1 and 2.
  • the light transmittance was excellent as compared with the compositions of Comparative Examples 1 and 2, and it was confirmed that the yellowing property after the reliability evaluation was excellent.
  • the triazine derivative compound according to the present invention is used in a photosensitive composition and exhibits a high refractive index after the photo-crosslinking process, and solves the problem of color change of the optical sheet due to yellowing phenomenon according to the prior art, (DBEF) film, a coating material for an organic light emitting device (OLED), an optical lens, a multifocal lens, and the like can be provided. It is possible to apply it as a material for industrial application.

Landscapes

  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The present invention relates to a compound represented by any one of the following formula A to formula C, and a photosensitive composition comprising the same, wherein the structure of the compound represented by any one of formula A to formula C is as described in the detailed description of the invention.

Description

신규한 트리아진 유도체 및 이를 포함하는 감광성 조성물 Novel triazine derivatives and photosensitive compositions containing them
본 발명은 신규한 트리아진 유도체 및 이를 포함하는 감광성 조성물에 관한 것으로, 보다 상세하게는 광가교 공정 이후의 굴절율이 높으며, 광학 재료의 제조 공정에 있어, 경화성이 우수하고 경화 후 투과도가 높고 내황변 특성이 우수한 특성을 가지는, 신규한 트리아진 유도체 및 이를 포함하는 감광성 조성물에 관한 것이다.The present invention relates to a novel triazine derivative and a photosensitive composition containing the same, and more particularly to a novel triazine derivative having a high refractive index after a photo-crosslinking process, excellent curability in a process of producing an optical material, A novel triazine derivative having excellent properties and a photosensitive composition containing the novel triazine derivative.
액정표시장치(liquid crystal display, LCD)는 기재필름 및 기재필름 상에 형성된 광학패턴을 포함하는 광학시트를 포함하며, 광학시트 하부에는 도광판이 배치되거나 또는 광학시트와 도광판 사이에 또 다른 광학시트가 배치될 수 있다. A liquid crystal display (LCD) includes an optical sheet including an optical pattern formed on a base film and a base film, and a light guide plate is disposed under the optical sheet, or another optical sheet is provided between the optical sheet and the light guide plate .
여기서, 광학시트의 종류로는 반사시트 (reflector sheet), 확산시트 (diffuser sheet), 프리즘 시트(prism sheet), 마이크로렌즈 등이 있으며, 이러한 광학시트는 백라이트 유닛의 휘도를 향상시킬 목적으로 사용된다.Here, the types of optical sheets include a reflector sheet, a diffuser sheet, a prism sheet, These optical sheets are used for the purpose of improving the brightness of the backlight unit.
광학시트는 백라이트의 도광판으로부터 나오는 광을 굴절시켜 액정을 통과한 후에 화면에 출사시키는 방식으로 출사되는 빛의 휘도를 증가시키며, 액정표시장치의 휘도를 높이기 위해서는 프리즘 및 DBEF 등의 광학시트의 굴절율이 높아야 한다. The optical sheet increases the brightness of light emitted in such a manner that light emitted from the light guide plate of the backlight is refracted and transmitted to the screen after passing through the liquid crystal. In order to increase the brightness of the liquid crystal display device, the refractive index of the optical sheet such as prism and DBEF It should be high.
특히, LCD 패널 제조기술이 발전함에 따라 얇고 휘도가 높은 LCD 디스플레이에 대한 요구가 높아졌고, 이에 따라 백라이트 유닛의 휘도를 높이려는 다양한 시도가 있어 왔다.In particular, with the development of LCD panel manufacturing technology, there has been a demand for a thin and bright LCD display, and accordingly, various attempts have been made to increase the brightness of the backlight unit.
그러나, 종래의 고굴절 모노머는 굴절율이 낮아 휘도 향상 효과를 구현하는데 한계가 있었으며, 또한 광학시트의 굴절률을 높이는 경우에도 광학시트에 황변 현상이 발생하는 등의 문제가 있었다. However, the conventional high-refraction monomers have a low refractive index and thus have limitations in realizing brightness enhancement effects. Further, even when the refractive index of the optical sheet is increased, yellowing occurs in the optical sheet.
한편, 고굴절 모노머와 관련한 종래 기술로서, 한국등록특허공보 제10-1692343호(2016.12.28) 및 한국공개특허공보 제10-2017-0013674호(2017.02.07)에서는 고굴절 모노머로써 아크릴계 모노머를 제시하고 있다.On the other hand, as a conventional technique relating to high refractive index monomers, Korean Patent Registration No. 10-1692343 (2016.12.28) and Korean Patent Laid-Open Publication No. 10-2017-0013674 (2017.02.07) propose an acrylic monomer as a high refractive index monomer have.
그러나, 상기 선행기술들을 포함하는 종래기술에도 불구하고, 액정표시장치의 휘도 향상을 위해서 투과도와 내황변 특성이 우수하고, 높은 고굴절 특성을 갖는 고굴절 모노머 재료가 요구되고 있는 실정이며, 따라서 새로운 고굴절 모노머의 개발 필요성은 지속적으로 요구되고 있다. However, in spite of the prior art including the above-mentioned prior arts, there is a demand for a high-refraction monomer material having a high transmittance and an excellent yellowing resistance characteristic and a high high-refraction property in order to improve the brightness of a liquid crystal display. The need for the development of new technologies is constantly being sought.
따라서, 본 발명이 이루고자 하는 첫 번째 기술적 과제는 높은 투과도와, 우수한 광가교 특성 및 내황변 특성을 가지며, 특히 고굴절 특성을 가지는 감광성 조성물에 모노머로서 사용될 수 있는 신규한 트리아진 유도체 화합물을 제공하는 것이다. Accordingly, a first technical object of the present invention is to provide a novel triazine derivative compound which has high transmittance, excellent light-crosslinking property and yellowing resistance, and which can be used as a monomer in a photosensitive composition having high refractive index .
또한, 본 발명에 따른 두 번째 기술적 과제는 상기 트리아진 유도체 화합물을 포함하는 감광성 조성물 및 이를 중합하여 얻어지는 광학 물품을 제공하는 것이다.A second technical object of the present invention is to provide a photosensitive composition comprising the triazine derivative compound and an optical article obtained by polymerizing the same.
상기 과제를 위해, 본 발명은 하기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물을 제공한다.To this end, the present invention provides a compound represented by any one of the following formulas (A) to (C).
[화학식 A](A)
Figure PCTKR2018010549-appb-I000001
Figure PCTKR2018010549-appb-I000001
상기 [화학식 A]에서, In the above formula (A)
상기 Ra는 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기에서 선택되는 어느 하나의 치환기이고,Ra is any substituent selected from hydrogen, deuterium, substituted or unsubstituted C 1 -C 6 alkyl group,
상기 L1 은 단일결합, O, S, -N(-R5)- 중에서 선택된 어느 하나이며, Wherein L1 is a single bond, O, S, or -N (-R5) -,
상기 L2는 단일결합, O, S, -N(-R6)- 중에서 선택된 어느 하나이며, L2 is a single bond, O, S, or -N (-R6) -,
상기 X1 내지 X3는 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, O, S, -N(-R7)-, -O((CH2)mO)n- 중에서 선택된 어느 하나이되, 상기 m 및 n은 각각 동일하거나 상이하며, 서로 독립적으로 1 내지 4 중에서 선택되는 정수이고, 상기 X1 내지 X3 중 2이상이 각각 -N(-R7)- 를 선택하거나 또는 상기 X1 내지 X3 중 2이상이 각각 -O((CH2)mO)n-를 선택하는 경우에 각각의 -N(-R7)- 및 -O((CH2)mO)n-는 각각 동일하거나 상이하며, X 1 to X 3 are the same or different and independently of each other are a single bond, O, S, -N (-R 7) - or -O ((CH 2 ) m O) n - n is an integer selected from 1 to 4, and at least two of X1 to X3 each represent -N (-R7) -, or two or more of X1 to X3 each independently represent - O ((CH 2) m O ) n - each -N (-R7) in the case of selecting - and -O ((CH 2) m O ) n - may be identical to or different from each other, and
상기 R4 내지 R7 은 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C50의 아릴기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C7-C24의 아릴알킬기 중에서 선택된 어느 하나이고, Wherein R4 to R7 are the same or different, independently represent hydrogen, deuterium, substituted or unsubstituted C 1 -C 30 an alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted C 6 -C 50 ring, each ring of A C 3 -C 30 cycloalkyl group, and a substituted or unsubstituted C 7 -C 24 arylalkyl group,
상기 W1은 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기 중에서 선택되는 어느 하나이고,Wherein W1 is any one selected from an alkylene group of a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, a substituted or unsubstituted C 1 -C 12 a,
상기 W2 및 W3는 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, 치환 또는 비치환된 C1-C30의 알킬렌기, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C2-C30의 알케닐렌기, 치환 또는 비치환된 C3-C30의 시클로알킬렌기, 치환 또는 비치환된 C5-C30의 시클로알케닐렌기, 치환 또는 비치환된 C2-C50의 헤테로아릴렌기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬렌기 중에서 선택되는 어느 하나이며,Wherein W2 and W3 are the same or different and each independently represent a single bond, a substituted or unsubstituted C 1 a C 6 aryl group, a substituted or unsubstituted ring of -C 30 alkylene group, a substituted or unsubstituted -C 30 unsubstituted C 2 -C 30 of alkenylene group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group, the substituted or unsubstituted C 2 -C 50 hetero arylene group, and any one is selected from a substituted or unsubstituted heterocycloalkyl group of C 2 -C 30 a,
상기 Y1 및 Y2는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C2-C30의 알케닐기, 치환 또는 비치환된 C2-C20의 알키닐기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C5-C30의 시클로알케닐기, 치환 또는 비치환된 C2-C50의 헤테로아릴기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬기, 치환 또는 비치환된 C1-C30의 알킬실릴기, 치환 또는 비치환된 C6-C30의 아릴실릴기 및, 하기 구조식 1 또는 구조식 2 로 표시되는 치환기 중에서 선택된 어느 하나이며,Wherein Y1 and Y2 are the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or non-substituted of unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 of each ring C, respectively of 2 -C 30 alkenyl group, a substituted or unsubstituted C 2 -C 20 alkynyl of the group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group , A substituted or unsubstituted C 2 -C 50 heteroaryl group, a substituted or unsubstituted C 2 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 1 -C 30 alkylsilyl group, a substituted or unsubstituted A C 6 -C 30 arylsilyl group, and a substituent group represented by the following structural formula 1 or 2,
[구조식 1] [구조식 2][Structural formula 1] [Structural formula 2]
Figure PCTKR2018010549-appb-I000002
Figure PCTKR2018010549-appb-I000002
상기 [구조식 1]과 [구조식 2]에서, In the above Structural Formula 1 and Structural Formula 2,
상기 Rb 및 Rc 는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기 중에서 선택된 어느 하나이며, Wherein Rb and Rc are each the same or different, and independently are any one selected from the group consisting of hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6 with each other,
상기 구조식 1 및 구조식2 내 “-*”는 각각 상기 화학식 A내 X2 또는 X3와 결합되는 결합 사이트를 의미하고,"- *" in the structural formulas 1 and 2 means a bonding site in which X2 or X3 in the above formula (A) is bonded,
[화학식 B][Chemical Formula B]
Figure PCTKR2018010549-appb-I000003
Figure PCTKR2018010549-appb-I000003
[화학식 C]≪ RTI ID = 0.0 &
Figure PCTKR2018010549-appb-I000004
Figure PCTKR2018010549-appb-I000004
상기 [화학식 B]에서, In the above formula (B)
상기 Ar1은 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C2-C30의 헤테로아릴렌기, 치환 또는 비치환된 C1-C30의 알킬렌기, 치환 또는 비치환된 C2-C30의 알케닐렌기, 치환 또는 비치환된 C3-C30의 시클로알킬렌기, 치환 또는 비치환된 C5-C30의 시클로알케닐렌기 중에서 선택되는 어느 하나이고,Wherein Ar 1 is a substituted or unsubstituted C 6 -C 30 arylene group, a substituted or unsubstituted C 2 -C 30 heteroarylene group, a substituted or unsubstituted C 1 -C 30 alkylene group, and the one which is C 2 -C 30 alkenylene group, selected from substituted or unsubstituted C 3 -C 30 cycloalkylene group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group of the,
L6은 단일결합, O, S, -N(-R11)- 중에서 선택된 어느 하나이고,L6 is any one selected from a single bond, O, S, -N (-R11) -,
L7은 단일결합, O, S, -N(-R12)- 중에서 선택된 어느 하나이며,L7 is any of a single bond, O, S, -N (-R12) -,
상기 [화학식 C]에서, In the above formula (C)
상기 Ar2는 수소, 중수소, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C2-C30의 헤테로아릴기, 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C2-C30의 알케닐기, 치환 또는 비치환된 C5-C30의 시클로알케닐기 중에서 선택되는 어느 하나이고,Substituted or unsubstituted C 6 -C 30 aryl group, substituted or unsubstituted C 2 -C 30 heteroaryl group, substituted or unsubstituted C 1 -C 30 alkyl group, substituted Or an unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 2 -C 30 alkenyl group, or a substituted or unsubstituted C 5 -C 30 cycloalkenyl group,
상기 [화학식 B] 내지 [화학식 C]에서, In the above formulas (B) to (C)
상기 Rd는 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기에서 선택되는 어느 하나의 치환기이고,Wherein Rd is a substituent of any one selected from hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6,
상기 L3 내지 L5는 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, O, S, -N(-R9)- 중에서 선택된 어느 하나이며,Each of L3 to L5 is the same or different and independently selected from a single bond, O, S, or -N (-R9) -,
상기 L3 내지 L5 중 2이상이 각각 -N(-R9)- 를 선택하는 경우에 각각의 -N(-R9)는 동일하거나 상이하며,When two or more of L3 to L5 each represent -N (-R9) -, each of -N (-R9) is the same or different,
상기 X4 내지 X7은 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, O, S, -N(-R10)-, -O((CH2)mO)n- 중에서 선택된 어느 하나이되, 상기 m 및 n은 각각 동일하거나 상이하며, 서로 독립적으로 1 내지 4 중에서 선택되는 정수이고,Wherein X4 to X7 are the same or different and each, independently of one another a single bond, O, S, -N (-R10 ) -, -O ((CH 2) m O) n - are optionally replaced with one selected from said m and n are the same or different and are each independently an integer selected from 1 to 4,
상기 X4 내지 X7 중 2이상이 각각 -N(-R10)-를 선택하거나, 또는 상기 X4 내지 X7 중 2이상이 각각 -O((CH2)mO)n-를 선택하는 경우에 각각의 -N(-R10)- 및 -O((CH2)mO)n-는 동일하거나 상이하며,The at least two of the X4 to X7 -N (-R10) respectively select, or at least two of the X4 to X7 is n -O ((CH 2) m O) , respectively - if the select on each - N (-R 10) - and -O ((CH 2 ) m O) n - are the same or different,
상기 R8 내지 R12는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C7-C24의 아릴알킬기 중에서 선택된 어느 하나이고, Wherein R8 to R12 are the same or different, independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or unsubstituted of C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 ring, each ring of the A C 3 -C 30 cycloalkyl group, and a substituted or unsubstituted C 7 -C 24 arylalkyl group,
상기 W4는 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기 중에서 선택되는 어느 하나이고,W4 is any one selected from the group consisting of a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, and a substituted or unsubstituted C 1 -C 12 alkylene group,
상기 W5 내지 W7은 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, 치환 또는 비치환된 C1-C30의 알킬렌기, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C2-C30의 알케닐렌기, 치환 또는 비치환된 C3-C30의 시클로알킬렌기, 치환 또는 비치환된 C5-C30의 시클로알케닐렌기, 치환 또는 비치환된 C2-C50의 헤테로아릴렌기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬렌기 중에서 선택되는 어느 하나이며,The W5 to W7 are the same or different and each independently represent a single bond, a substituted or unsubstituted C 1 -C 30 an alkyl group, an arylene group, a substituted or unsubstituted substituted or unsubstituted C 6 -C 30 unsubstituted C 2 -C 30 of alkenylene group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group, the substituted or unsubstituted C 2 -C 50 hetero arylene group, and any one is selected from a substituted or unsubstituted heterocycloalkyl group of C 2 -C 30 a,
상기 Y3 내지 Y5는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C2-C30의 알케닐기, 치환 또는 비치환된 C2-C20의 알키닐기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C5-C30의 시클로알케닐기, 치환 또는 비치환된 C2-C50의 헤테로아릴기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬기, 치환 또는 비치환된 C1-C30의 알킬실릴기, 치환 또는 비치환된 C6-C30의 아릴실릴기 및, 하기 [구조식 1] 또는 [구조식 2]로 표시되는 치환기 중에서 선택된 어느 하나이며,The Y3 to Y5 are the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or non-substituted of unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 of each ring C, respectively of 2 -C 30 alkenyl group, a substituted or unsubstituted C 2 -C 20 alkynyl of the group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group , A substituted or unsubstituted C 2 -C 50 heteroaryl group, a substituted or unsubstituted C 2 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 1 -C 30 alkylsilyl group, a substituted or unsubstituted A C 6 -C 30 arylsilyl group, and a substituent group represented by the following structural formula 1 or 2:
[구조식 1] [구조식 2][Structural formula 1] [Structural formula 2]
Figure PCTKR2018010549-appb-I000005
Figure PCTKR2018010549-appb-I000005
상기 [구조식 1]과 [구조식 2]에서, In the above Structural Formula 1 and Structural Formula 2,
상기 Rb 및 Rc는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기 중에서 선택된 어느 하나이며,Wherein Rb and Rc are each the same or different, and independently are any one selected from the group consisting of hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6 with each other,
상기 구조식 1 및 구조식2 내 “-*”는 각각 상기 [화학식 B] 또는 [화학식 C]내 X5 내지 X7과 결합되는 결합 사이트를 의미하고,"- *" in the structural formulas 1 and 2 means a binding site in which X5 to X7 in the above-mentioned formula (B) or (C) are bonded,
여기서, 상기 [화학식 A] 내지 [화학식 C]에서의 ‘치환 또는 비치환된’에서의 ‘치환’은 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, C1-C24의 알킬기, C1-C24의 할로겐화된 알킬기, C2-C24의 알케닐기, C2-C24의 알키닐기, C1-24의 헤테로알킬기, C6-C24의 아릴기, C7-C24의 아릴알킬기, C2-C24의 헤테로아릴기, C2-C24의 헤테로아릴알킬기, C1-C24의 알콕시기, C1-C24의 알킬티오닐기, C1-C24의 알킬아미노기, C6-C24의 아릴아미노기, C1-C24의 헤테로 아릴아미노기, C1-C24의 알킬실릴기, C6-C24의 아릴실릴기, C6-C24의 아릴옥시기, C6-C24의 아릴티오닐기로 이루어진 군에서 선택된 1개 이상의 치환기로 치환되는 것을 의미한다.Here, the above-mentioned [Chemical Formula A] to [Chemical Formula C] "substituted" in the "substituted or unsubstituted" in the heavy hydrogen, a cyano group, a halogen group, a hydroxyl group, a nitro group, an alkyl group of C 1 -C 24, C 1 -C 24 halogenated alkyl group, C 2 -C 24 alkenyl, C 2 -C 24 alkynyl group of, C 1 - 24 heterocyclic group in the alkyl group, C 6 -C 24 aryl, C 7 -C 24 aryl An alkyl group, a C 2 -C 24 heteroaryl group, a C 2 -C 24 heteroarylalkyl group, a C 1 -C 24 alkoxy group, a C 1 -C 24 alkylthioyl group , a C 1 -C 24 alkylamino group , A C 6 -C 24 arylamino group, a C 1 -C 24 heteroarylamino group, a C 1 -C 24 alkylsilyl group, a C 6 -C 24 arylsilyl group, a C 6 -C 24 aryloxy group, And an arylthionyl group having 6 to 24 carbon atoms.
또한 본 발명은 상기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물을 포함하는 감광성 조성물 및 이를 중합하여 얻어지는 광학 소재 또는 광학 물품을 제공한다.The present invention also provides a photosensitive composition comprising a compound represented by any one of the above-mentioned formulas (A) to (C) and an optical material or an optical article obtained by polymerizing the same.
본 발명에 따른 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 신규한 트리아진 유도체 화합물은 감광성 조성물에 이용되어 광가교 공정 이후의 굴절율이 높은 특성을 제공할 수 있다. The novel triazine derivative compounds represented by any one of the formulas (A) to (C) according to the present invention can be used in a photosensitive composition to provide a property of high refractive index after the photo-crosslinking step.
특히, 높은 투과도와 내황변 특성이 우수한 감광성 조성물을 제공할 수 있어, 종래 기술에 따른, 굴절율이 낮아 휘도 향상 효과를 구현하는데 한계가 있고, 황변현상으로 인해 광학시트의 색변화되는 문제를 해결할 수 있는 효과가 있어, 프리즘 시트, 마이크로렌즈, LCD용 코팅 재료, DBEF(Dual Brightness Enhancement Film) 필름, 유기발광소자(OLED)용 코팅 재료, 광학렌즈, 다초점렌즈 등의 제조를 위한 용도에 적용 가능한 장점이 있다.In particular, it is possible to provide a photosensitive composition having a high transmittance and an excellent yellowing resistance characteristic, and has a limit in realizing a luminance improvement effect due to a low refractive index according to the prior art, and can solve the problem of color change of the optical sheet due to yellowing (DBEF) film, a coating material for an organic light emitting device (OLED), an optical lens, and a multifocal lens, which can be applied to a prism sheet, a microlens, a coating material for an LCD, a DBEF (Dual Brightness Enhancement Film) There are advantages.
이하, 본 발명을 더욱 상세하게 설명한다. 다른 식으로 정의되지 않는 한, 본 명세서에서 사용된 모든 기술적 및 과학적 용어들은 본 발명이 속하는 기술분야에서 숙련된 전문가에 의해서 통상적으로 이해되는 것과 동일한 의미를 가진다. 일반적으로, 본 명세서에서 사용된 명명법은 본 기술분야에서 잘 알려져 있고 통상적으로 사용되는 것이다.Hereinafter, the present invention will be described in more detail. Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In general, the nomenclature used herein is well known and commonly used in the art.
본원 명세서 전체에서, 어떤 부분이 어떤 구성 요소를 "포함" 한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다.Throughout this specification, when an element is referred to as " including " an element, it is understood that the element may include other elements as well, without departing from the other elements unless specifically stated otherwise.
본 발명에 따른 상기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물은 1 내지 3개의 트리아진 구조를 포함하며, 트리아진의 각각의 탄소원자에 N, O, S, 또는 단일결합을 가지는 제1연결부분; 단일결합, 알킬렌기 또는 아릴렌기를 포함하는 제2연결부분; 및 N, O, S, 알킬렌옥사이드 또는 단일결합을 가지는 제3연결부분;을 포함하며, 말단에 적어도 하나이상의 아크릴산 유도체 등의 이중결합을 포함하는 구조로서, 여기서 트리아진의 탄소원자 3개 중에 적어도 하나의 탄소원자에는 질소가 결합되고, 그 말단이 아크릴산 유도체 등의 이중결합을 포함하는 구조를 갖는 것을 기술적 특징으로 한다. The compound represented by any one of the above-mentioned formulas (A) to (C) according to the present invention contains 1 to 3 triazine structures and may contain N, O, S or a single bond to each carbon atom of the triazine A first connecting portion; A second connecting portion comprising a single bond, an alkylene group or an arylene group; And a third connecting portion having N, O, S, alkylene oxide, or a single bond, and having a double bond such as at least one acrylic acid derivative at the terminal, wherein, among three carbon atoms of triazine, A technical feature is that a nitrogen atom is bonded to at least one carbon atom and a terminal thereof has a double bond such as an acrylic acid derivative.
여기서, 상기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 트리아진 화합물을 포함하는 감광성 조성물을 모노머로서 사용하는 경우, 굴절율과 투과도가 높고 우수한 내황변 특성을 나타낼 수 있다.Here, when a photosensitive composition comprising a triazine compound represented by any one of the above-mentioned formulas (A) to (C) is used as a monomer, a high refractive index and high transmittance can be exhibited and excellent yellowing resistance can be exhibited.
한편, 본 발명에서의 상기 “치환 또는 비치환된 C1-C20의 알킬기”, “치환 또는 비치환된 C6-C50의 아릴기” 등에서의 상기 알킬기 또는 아릴기의 범위를 고려하여 보면, 상기 C1-C20의 알킬기 및 C6-C50의 아릴기의 탄소수의 범위는 각각 상기 치환기가 치환된 부분을 고려하지 않고 비치환된 것으로 보았을 때의 알킬 부분 또는 아릴 부분을 구성하는 전체 탄소수를 의미하는 것이다. 예컨대, 파라위치에 부틸기가 치환된 페닐기는 C4의 부틸기로 치환된 C6의 아릴기에 해당하는 것으로 보아야 한다. In consideration of the range of the alkyl group or the aryl group in the "substituted or unsubstituted C 1 -C 20 alkyl group" or the "substituted or unsubstituted C 6 -C 50 aryl group" in the present invention , The carbon numbers of the C 1 -C 20 alkyl group and the C 6 -C 50 aryl group are each an alkyl moiety or an aryl moiety constituting the alkyl moiety or the aryl moiety when considered to be unsubstituted, Means the number of carbon atoms. For example, a phenyl group substituted with a butyl group at the para position should be considered to correspond to a C 6 aryl group substituted with a C 4 butyl group.
본 발명의 화합물에서 사용되는 치환기인 아릴기는 하나의 수소 제거에 의해서 방향족 탄화수소로부터 유도된 유기 라디칼로, 5 내지 7원, 바람직하게는 5 또는 6원을 포함하는 단일 또는 융합고리계를 포함하며, 또한 상기 아릴기에 치환기가 있는 경우 이웃하는 치환기와 서로 융합 (fused)되어 고리를 추가로 형성할 수 있다.The aryl group which is a substituent used in the compound of the present invention is an organic radical derived from an aromatic hydrocarbon by one hydrogen elimination and includes a single or fused ring system containing 5 to 7 atoms, preferably 5 or 6 atoms, When a substituent is present in the aryl group, the adjacent substituent may be fused with each other to form a ring.
상기 아릴기의 구체적인 예로는 페닐기, o-비페닐기, m-비페닐기, p-비페닐기, o-터페닐기, m-터페닐기, p-터페닐기, 나프틸기, 안트릴기, 페난트릴기, 피레닐기, 인데닐, 플루오레닐기, 테트라히드로나프틸기, 페릴렌일, 크라이세닐, 나프타세닐, 플루오란텐일등과 같은 방향족 그룹을 들 수 있고, 상기 아릴기 중 하나 이상의 수소 원자는 중수소 원자, 할로겐 원자, 히드록시기, 니트로기, 시아노기, 실릴기, 아미노기 (-NH2, -NH(R), -N(R')(R''), R'과 R"은 서로 독립적으로 C1-C10의 알킬기이며, 이 경우 "알킬아미노기"라 함), 아미디노기, 히드라진기, 히드라존기, 카르복실기, 술폰산기, 인산기, C1-C24의 알킬기, C1-C24의 할로겐화된 알킬기, C2-C24의 알케닐기, C2-C24의 알키닐기, C1-C24의 헤테로알킬기, C6-C24의 아릴기, C7-C24의 아릴알킬기, C2-C24의 헤테로아릴기 또는 C2-C24의 헤테로아릴알킬기로 치환될 수 있다.Specific examples of the aryl group include a phenyl group, o-biphenyl group, m-biphenyl group, p-biphenyl group, o-terphenyl group, m- terphenyl group, p- terphenyl group, naphthyl group, anthryl group, An aromatic group such as a pyridyl group, an indenyl group, a fluorenyl group, a tetrahydronaphthyl group, a perylenyle, a crycenyl, a naphthacenyl, a fluoranthene and the like, and at least one hydrogen atom of the aryl group may be substituted with a deuterium atom, atom, a hydroxy group, a nitro group, a cyano group, a silyl group, an amino group (-NH2, -NH (R), -N (R ') (R''),R' and R "are independently from each other C 1 -C 10 an alkyl group, in which case the "alkyl group" hereinafter), an amidino group, a hydrazine group, a hydrazone jongi, a carboxyl group, a sulfonic acid group, phosphoric acid group, an alkyl group, a halogenated alkyl group of C 1 -C 24 in C 1 -C 24, C 2 -C 24 alkenyl group, an arylalkyl group of C 2 -C 24 alkynyl group of, C 1 -C 24 heterocyclic group, C 6 -C 24 aryl group, C 7 -C 24 a, C 2 -C 24 A heteroaryl group of a heteroaryl group or C 2 -C 24 which may be substituted.
본 발명의 화합물에서 사용되는 치환기인 헤테로아릴기는 아릴기에서 N, O, P, Si, S, Ge, Se, Te 중에서 선택된 1, 2 또는 3개의 헤테로 원자를 포함하고, 나머지 고리 원자가 탄소인 C2-C24의 고리 방향족 시스템을 의미하며, 상기 고리들은 융합(fused)되어 고리를 형성할 수 있다. 그리고 상기 헤테로아릴기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.The heteroaryl group which is a substituent used in the compound of the present invention is a heteroaryl group having 1, 2 or 3 hetero atoms selected from N, O, P, Si, S, Ge, Se and Te in the aryl group, Means a C 2 -C 24 ring aromatic system, which rings can be fused to form a ring. And at least one hydrogen atom of the heteroaryl group may be substituted with the same substituent as the aryl group.
또한 본 발명에서 사용되는 치환기인 알킬기의 구체적인 예로는 메틸, 에틸, 프로필, 이소프로필, 이소부틸, sec-부틸, tert-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있고, 상기 알킬기 중 하나 이상의 수소 원자는 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.Specific examples of the alkyl group as a substituent used in the present invention include methyl, ethyl, propyl, isopropyl, isobutyl, sec-butyl, tert-butyl, pentyl, iso-amyl and hexyl. The hydrogen atoms of the above hydrogen atoms can be substituted with the same substituents as those in the aryl group.
본 발명의 화합물에서 사용되는 치환기인 알콕시기의 구체적인 예로는 메톡시, 에톡시, 프로폭시, 이소부틸옥시, sec-부틸옥시, 펜틸옥시, iso-아밀옥시, 헥실옥시 등을 들 수 있고, 상기 알콕시기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.Specific examples of the alkoxy group used as the substituent in the compound of the present invention include methoxy, ethoxy, propoxy, isobutyloxy, sec-butyloxy, pentyloxy, iso-amyloxy, hexyloxy, At least one hydrogen atom in the alkoxy group may be substituted with the same substituent as in the case of the aryl group.
본 발명의 화합물에서 사용되는 치환기인 알킬아릴기의 구체적인 예로는 메틸페닐, 디메틸페닐, n-프로필페닐, t-부틸페닐, 메틸나프틸 등을 들 수 있고, 상기 알킬아릴기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.Specific examples of the alkylaryl group used as the substituent in the compound of the present invention include methylphenyl, dimethylphenyl, n -propylphenyl, t -butylphenyl, methylnaphthyl and the like, May be substituted with the same substituents as those in the aryl group.
본 발명의 화합물에서 사용되는 치환기인 시클로알킬기의 구체적인 예로는 시클로부틸, 시클로펜틸, 시클로헥실, 메틸시클로펜틸, 메틸시클로헥실, 에틸시클로펜틸, 에틸시클로헥실 등을 들 수 있고, 상기 시클로알킬기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능 하다.Specific examples of the cycloalkyl group as the substituent used in the compound of the present invention include cyclobutyl, cyclopentyl, cyclohexyl, methylcyclopentyl, methylcyclohexyl, ethylcyclopentyl and ethylcyclohexyl, and one of the cycloalkyl groups The above hydrogen atoms may be substituted with substituents similar to those in the aryl group.
본 발명의 화합물에서 사용되는 치환기인 실릴기의 구체적인 예로는 트리메틸실릴, 트리에틸실릴, 트리페닐실릴, 트리메톡시실릴, 디메톡시페닐실릴, 디페닐메틸실릴, 디페닐비닐실릴, 메틸사이클로뷰틸실릴, 디메틸퓨릴실릴 등을 들 수 있고, 상기 실릴기 중 하나 이상의 수소 원자는 상기 아릴기의 경우와 마찬가지의 치환기로 치환가능하다.Specific examples of the silyl group used as the substituent in the compound of the present invention include trimethylsilyl, triethylsilyl, triphenylsilyl, trimethoxysilyl, dimethoxyphenylsilyl, diphenylmethylsilyl, diphenylvinylsilyl, methylcyclobutylsilyl , And dimethylpurylsilyl. At least one hydrogen atom of the silyl group may be substituted with the same substituent as the aryl group.
한편, 본 발명에서의 상기 화학식 A내 치환기 R4 내지 R6는 바람직하게는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C20의 알킬기, 치환 또는 비치환된 C6-C20의 아릴기 중에서 선택되는 어느 하나이고, Ra, Rb 및 Rc 는 바람직하게는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 메틸기 에서 선택되는 어느 하나의 치환기 일 수 있다. On the other hand, to within the substituent R4 of the formula (A) in the present invention, R6 is preferably the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted C 1 -C 20 alkyl group, a substituted or unsubstituted C of each other, respectively And an aryl group having 6 to 20 carbon atoms, and Ra, Rb and Rc are preferably the same or different, and independently of each other may be any substituent selected from hydrogen and a deuterated methyl group.
또한, 상기 화학식 A내 Y1 및 Y2 중 적어도 하나는 구조식 1 또는 구조식 2일 수 있고, 이러한 구조를 가짐으로써, 모노머의 양말단이 이중결합을 가지게 되어 광중합시 광가교 속도를 조절할 수 있다.At least one of Y1 and Y2 in formula (A) may be a structural formula (1) or a structural formula (2). By having such a structure, both ends of a monomer have a double bond, and the photocatalytic rate can be controlled during photopolymerization.
또한, 상기 화학식 A내 L1 은 -N(-R5)- 또는 S 이고, L2 는 -N(-R6)- 또는 S 일 수 있으며, 더욱 바람직하게는 상기 L1은 -N(-R5)- 이고, L2 는 -N(-R6)- 이며, 상기 R5 및 R6은 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, C1-C10의 알킬기, C6-C20의 아릴기 중에서 선택되는 어느 하나일 수 있다.L 1 in the formula (A) may be -N (-R 5) - or S, L 2 may be -N (-R 6) - or S, more preferably L 1 is -N (-R 5) L2 is a -N (-R6) -, and wherein R5 and R6 are either same or different and are each, independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 of Lt; / RTI >
즉, 상기 화학식 A내 L1 및 L2는 각각 질소 원자 또는 황원자를 포함할 수 있으며, 질소원자 또는 황원자를 포함하는 경우에는 투과도가 우수하면서도 굴절율이 높은 특성을 가지게 되어 더욱 바람직하다.That is, in the formula (A), L 1 and L 2 may each contain a nitrogen atom or a sulfur atom, and when they contain a nitrogen atom or a sulfur atom, they are more preferable since they have a high transparency and a high refractive index.
또한, 본 발명에서의 상기 화학식 A내 W1 내지 W3 중 적어도 하나는 치환 또는 비치환된 C6-C30의 아릴렌기일 수 있고, 바람직하게는, W1 내지 W3 중 두 개가 치환 또는 비치환된 C6-C30의 아릴렌기이거나 또는 W1 내지 W3 모두 치환 또는 비치환된 C6-C30의 아릴렌기일 수 있다. In addition, at least one of the formula (A) in W1 to W3 in the present invention is substituted or unsubstituted C 6 arylene group may be the date -C 30 ring, preferably, W1 to two are a substituted or unsubstituted C of W3 6 or an aryl group of 30 or -C W1 to W3 can all arylene date of substituted or unsubstituted C 6 -C 30.
이 경우에 상기 C6-C30의 아릴렌기의 아로마틱 평면구조와 트리아진의 평면 구조로 인하여 판상구조를 형성하여 이로 인하여 높은 고굴절 특성이 나타날 수 있는 것으로 추정된다. In this case, it is presumed that the plate structure is formed due to the aromatic plane structure of the C 6 -C 30 arylene group and the plane structure of the triazine, and thus high high-refraction characteristics can be obtained.
예컨대, 상기 화학식 A내 W1 내지 W3 중 적어도 하나는 치환 또는 비치환된 C6-C30의 아릴렌기의 구체적인 예로서, 상기 화학식 A내 W1은 치환 또는 비치환된 페닐렌기이고, 상기 W2 및 W3는 동일하거나 상이하며, 서로 독립적으로 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기일 수 있다.For example, at least one of the formula (A) in W1 to W3 is a substituted or Examples of the unsubstituted aryl group of C 6 -C 30, wherein the formula (A) in W1 is a substituted or unsubstituted phenylene group ring, wherein W2 and W3 May be the same or different and independently of each other, a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, or a substituted or unsubstituted C 1 -C 12 alkylene group.
또한, 상기 W1 내지 W3 중 두 개이상이 치환 또는 비치환된 C6-C30의 아릴렌기인 경우의 구체적인 예로서, 상기 W1은 치환 또는 비치환된 페닐렌기이고, 상기 W2 및 W3 는 동일하거나 상이하며, 이들 중 적어도 하나는 치환 또는 비치환된 C6-C30의 아릴렌기 인 경우와, 상기 W1 내지 W3 는 각각 동일하거나 상이하며, 이들 중 적어도 2개는 치환 또는 비치환된 페닐렌기 인 경우를 들 수 있으며, 또는, 상기 W1 내지 W3 는 각각 동일하거나 상이하며, 모두가 치환 또는 비치환된 페닐렌기 인 경우를 들 수 있다.As a specific example of the case where two or more of W1 to W3 are substituted or unsubstituted C 6 -C 30 arylene groups, W 1 is a substituted or unsubstituted phenylene group, W 2 and W 3 are the same At least one of them is a substituted or unsubstituted C 6 -C 30 arylene group, and W 1 to W 3 are the same or different, and at least two of them are a substituted or unsubstituted phenylene group Or W1 to W3 are the same or different and each is a substituted or unsubstituted phenylene group.
한편, 본 발명에서의 상기 [화학식 B] 및 [화학식 C]내 치환기 R8 내지 R12는 바람직하게는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C20의 알킬기, 치환 또는 비치환된 C6-C20의 아릴기 중에서 선택되는 어느 하나이고, Ra, Rb 및 Rc 는 바람직하게는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 메틸기에서 선택되는 어느 하나의 치환기 일 수 있다. On the other hand, the above-mentioned [Chemical Formula B] and [Chemical Formula C] within substituents R8 to R12 are preferably identical or different and, independently from each other hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 20 respectively according to the present invention , substituted or unsubstituted and which is selected from aryl groups unsubstituted C 6 -C 20 a, Ra, Rb and Rc is preferably any of the substituents, the same or different and independently selected from hydrogen, deuterium, a methyl group from each other, respectively Lt; / RTI >
또한, 상기 [화학식 B] 및 [화학식 C]내 Y3 및 Y5 중 적어도 하나는 구조식 1 또는 구조식 2일 수 있고, 이러한 구조를 가짐으로써, 모노머의 양말단이 이중결합을 가지게 되어 광중합시 광가교 속도를 조절할 수 있다.At least one of Y 3 and Y 5 in the above formulas (B) and (C) may be a structural formula 1 or a structural formula 2. By having such a structure, both ends of the monomer have a double bond, Can be adjusted.
또한, 상기 [화학식 B]내 L3 내지 L7은 각각 동일하거나 상이하며 서로 독립적으로 단일결합, -N(-R9)- 또는 S일 수 있으며, 상기 L3 내지 L7 중 2이상이 각각 -N(-R9)-를 선택하는 경우에 각각의 -N(-R9)-는 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, C1-C10의 알킬기, C6-C20의 아릴기 중에서 선택되는 어느 하나일 수 있다.In the formula (B), L 3 to L 7 are the same or different and independently of each other, a single bond, -N (-R 9) - or S, and two or more of L 3 to L 7 are each -N ) each in the case of selecting -N (-R9) - are either the same or different, independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 of Lt; / RTI >
또한, 상기 [화학식 C]내 L3 내지 L5는 각각 동일하거나 상이하며 서로 독립적으로 단일결합, -N(-R9)- 또는 S일 수 있으며, 상기 L3 내지 L5 중 2이상이 각각 -N(-R9)-를 선택하는 경우에 각각의 -N(-R9)-는 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, C1-C10의 알킬기, C6-C20의 아릴기 중에서 선택되는 어느 하나일 수 있다.In the above formula (C), L3 to L5 are the same or different and independently of each other, a single bond, -N (-R9) - or S, and two or more of L3 to L5 are each -N ) each in the case of selecting -N (-R9) - are either the same or different, independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 of Lt; / RTI >
여기서, 상기 [화학식 B] 및 [화학식 C]내 L3 내지 L7은 각각 질소 원자 또는 황원자를 포함할 수 있으며, 질소원자 또는 황원자를 포함하는 경우에는 투과도가 우수하면서도 굴절율이 높은 특성을 가지게 되어 더욱 바람직하다.Herein, L3 to L7 in the above formulas (B) and (C) may contain a nitrogen atom or a sulfur atom, and when they contain a nitrogen atom or a sulfur atom, they have a high transparency and a high refractive index, Do.
상기 [화학식 B] 및 [화학식 C]내 R9, R11 내지 R12는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, C1-C10의 알킬기, C6-C20의 아릴기 중에서 선택되는 어느 하나일 수 있다.The one selected from Formula B] and [Chemical Formula C] within R9, R11 to R12 are the same or different and each independently represent hydrogen, deuterium, aryl group of C 1 -C 10 alkyl, C 6 -C 20 of each other It can be one.
또한, 본 발명에서의 상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 2개가 치환 또는 비치환된 C6-C30의 아릴렌기이거나 또는, W4 내지 W7 중 3개 이상이 치환 또는 비치환된 C6-C30의 아릴렌기이거나, 또는 W4 내지 W7 모두 치환 또는 비치환된 C6-C30의 아릴렌기일 수 있다. Further, the above-mentioned [Chemical Formula B] and [Chemical Formula C] within a W4 or to two of the aryl group a substituted or unsubstituted C 6 -C 30 or of W7, W4 to more than two of W7 is a substituted or unsubstituted according to the present invention hwandoen or C 6 -C 30 arylene group, or W4 through W7 may both be an arylene group substituted or unsubstituted C 6 -C 30.
이 경우에 상기 C6-C30의 아릴렌기의 아로마틱 평면구조와 트리아진의 평면 구조로 인하여 판상구조를 형성하여 이로 인하여 높은 고굴절 특성이 나타날 수 있는 것으로 추정된다. In this case, it is presumed that the plate structure is formed due to the aromatic plane structure of the C 6 -C 30 arylene group and the plane structure of the triazine, and thus high high-refraction characteristics can be obtained.
예컨대, 상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 2 개이상이 치환 또는 비치환된 C6-C30의 아릴렌기인 경우의 구체적인 예로서, 상기 W4 내지 W7 중 2 개이상이 치환 또는 비치환된 페닐렌기일 수 있다. For example, in the case where at least two of W4 to W7 in the above formulas (B) and (C) are substituted or unsubstituted C 6 -C 30 arylene groups, at least two of W 4 to W 7 Or a substituted or unsubstituted phenylene group.
이 경우에, 상기 W4 내지 W7 중 페닐렌기가 아닌 나머지 1개 또는 2개는 동일하거나 상이하며, 서로 독립적으로 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기일 수 있다.In this case, the W4 to the remaining one or two phenylene groups, not of W7 are the same or different and independently of each other a single bond, an arylene group, a substituted or unsubstituted substituted or unsubstituted C 6 -C 30 ring And may be a C 1 -C 12 alkylene group.
또한, 본 발명에서 상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 3 개이상이 치환 또는 비치환된 C6-C30의 아릴렌기인 경우의 구체적인 예로서, 상기 W4 내지 W7 중 3 개 또는 4개 모두가 치환 또는 비치환된 페닐렌기일 수 있다. 여기서 상기 상기 W4 내지 W7 중 3 개가 치환 또는 비치환된 페닐렌기인 경우에 페닐렌기가 아닌 나머지 1개는 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기일 수 있다.In the present invention, as a specific example of the case where at least three of W4 to W7 in the above formulas (B) and (C) are substituted or unsubstituted C 6 -C 30 arylene groups, And all or four of them may be a substituted or unsubstituted phenylene group. Wherein the W4 through W7 3 dogs substituted or unsubstituted on the remaining unsubstituted phenylene group is not phenylene group one is a single bond, a substituted or unsubstituted C 6 -C 30 aryl group, a substituted or unsubstituted C of Or an alkylene group of 1 to 12 carbon atoms.
또한, 본 발명에서의 상기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물의 구체적인 예로서는 하기 표 1에 기재된 화합물 1 내지 134 중의 어느 하나로 표시되는 화합물이 될 수 있으나, 이에 제한되지 않는다. Specific examples of the compounds represented by any one of the above-mentioned formulas (A) to (C) in the present invention may be compounds represented by any one of the compounds 1 to 134 described in the following Table 1, but are not limited thereto.
Figure PCTKR2018010549-appb-I000006
Figure PCTKR2018010549-appb-I000006
[화합물 1] [화합물 2][Compound 1] [Compound 2]
Figure PCTKR2018010549-appb-I000007
Figure PCTKR2018010549-appb-I000007
[화합물 3] [화합물 4][Compound 3] [Compound 4]
Figure PCTKR2018010549-appb-I000008
Figure PCTKR2018010549-appb-I000008
[화합물 5] [화합물 6][Compound 5] [Compound 6]
Figure PCTKR2018010549-appb-I000009
Figure PCTKR2018010549-appb-I000009
[화합물 7] [화합물 8] [Compound 7] [Compound 8]
Figure PCTKR2018010549-appb-I000010
Figure PCTKR2018010549-appb-I000010
[화합물 9] [화합물 10][Compound 9] [Compound 10]
Figure PCTKR2018010549-appb-I000011
Figure PCTKR2018010549-appb-I000011
[화합물 11] [화합물 12][Compound 11] [Compound 12]
Figure PCTKR2018010549-appb-I000012
Figure PCTKR2018010549-appb-I000012
[화합물 13] [화합물 14][Compound 13] [Compound 14]
Figure PCTKR2018010549-appb-I000013
Figure PCTKR2018010549-appb-I000013
[화합물 15] [화합물 16][Compound 15] [Compound 16]
Figure PCTKR2018010549-appb-I000014
Figure PCTKR2018010549-appb-I000014
[화합물 17] [화합물 18][Compound 17] [Compound 18]
Figure PCTKR2018010549-appb-I000015
Figure PCTKR2018010549-appb-I000015
[화합물 19] [화합물 20][Compound 19] [Compound 20]
Figure PCTKR2018010549-appb-I000016
Figure PCTKR2018010549-appb-I000016
[화합물 21] [화합물 22][Compound 21] [Compound 22]
Figure PCTKR2018010549-appb-I000017
Figure PCTKR2018010549-appb-I000017
[화합물 23] [화합물 24] [Compound 23] [Compound 24]
Figure PCTKR2018010549-appb-I000018
Figure PCTKR2018010549-appb-I000018
[화합물 25] [화합물 26][Compound 25] [Compound 26]
Figure PCTKR2018010549-appb-I000019
Figure PCTKR2018010549-appb-I000019
[화합물 27] [화합물 28][Compound 27] [Compound 28]
Figure PCTKR2018010549-appb-I000020
Figure PCTKR2018010549-appb-I000020
[화합물 29] [화합물 30][Compound 29] [Compound 30]
Figure PCTKR2018010549-appb-I000021
Figure PCTKR2018010549-appb-I000021
[화합물 31] [화합물 32][Compound 31] [Compound 32]
Figure PCTKR2018010549-appb-I000022
Figure PCTKR2018010549-appb-I000022
[화합물 33] [화합물 34][Compound 33] [Compound 34]
Figure PCTKR2018010549-appb-I000023
Figure PCTKR2018010549-appb-I000023
[화합물 35] [화합물 36][Compound 35] [Compound 36]
Figure PCTKR2018010549-appb-I000024
Figure PCTKR2018010549-appb-I000024
[화합물 37] [화합물 38][Compound 37] [Compound 38]
Figure PCTKR2018010549-appb-I000025
Figure PCTKR2018010549-appb-I000025
[화합물 39] [화합물 40][Compound 39] [Compound 40]
Figure PCTKR2018010549-appb-I000026
Figure PCTKR2018010549-appb-I000026
[화합물 41] [화합물 42][Compound 41] [Compound 42]
Figure PCTKR2018010549-appb-I000027
Figure PCTKR2018010549-appb-I000027
[화합물 43] [화합물 44][Compound 43] [Compound 44]
Figure PCTKR2018010549-appb-I000028
Figure PCTKR2018010549-appb-I000028
[화합물 45] [화합물 46][Compound 45] [Compound 46]
Figure PCTKR2018010549-appb-I000029
Figure PCTKR2018010549-appb-I000029
[화합물 47] [화합물 48][Compound 47] [Compound 48]
Figure PCTKR2018010549-appb-I000030
Figure PCTKR2018010549-appb-I000030
[화합물 49] [화합물 50][Compound 49] [Compound 50]
Figure PCTKR2018010549-appb-I000031
Figure PCTKR2018010549-appb-I000031
[화합물 51] [화합물 52][Compound 51] [Compound 52]
Figure PCTKR2018010549-appb-I000032
Figure PCTKR2018010549-appb-I000032
[화합물 53] [화합물 54][Compound 53] [Compound 54]
[화합물 55] [화합물 56][Compound 55] [Compound 56]
Figure PCTKR2018010549-appb-I000034
Figure PCTKR2018010549-appb-I000034
[화합물 57] [화합물 58][Compound 57] [Compound 58]
Figure PCTKR2018010549-appb-I000035
Figure PCTKR2018010549-appb-I000035
[화합물 59] [화합물 60][Compound 59] [Compound 60]
Figure PCTKR2018010549-appb-I000036
Figure PCTKR2018010549-appb-I000036
[화합물 61] [화합물 62][Compound 61] [Compound 62]
Figure PCTKR2018010549-appb-I000037
Figure PCTKR2018010549-appb-I000037
[화합물 63] [화합물 64][Compound 63] [Compound 64]
Figure PCTKR2018010549-appb-I000038
Figure PCTKR2018010549-appb-I000038
[화합물 65] [화합물 66][Compound 65] [Compound 66]
Figure PCTKR2018010549-appb-I000039
Figure PCTKR2018010549-appb-I000039
[화합물 67] [화합물 68][Compound 67] [Compound 68]
Figure PCTKR2018010549-appb-I000040
Figure PCTKR2018010549-appb-I000040
[화합물 69] [화합물 70][Compound 69] [Compound 70]
Figure PCTKR2018010549-appb-I000041
Figure PCTKR2018010549-appb-I000041
[화합물 71] [화합물 72][Compound 71] [Compound 72]
Figure PCTKR2018010549-appb-I000042
Figure PCTKR2018010549-appb-I000042
[화합물 73] [화합물 74][Compound 73] [Compound 74]
Figure PCTKR2018010549-appb-I000043
Figure PCTKR2018010549-appb-I000043
[화합물 75] [화합물 76][Compound 75] [Compound 76]
Figure PCTKR2018010549-appb-I000044
Figure PCTKR2018010549-appb-I000044
[화합물 77] [화합물 78][Compound 77] [Compound 78]
Figure PCTKR2018010549-appb-I000045
Figure PCTKR2018010549-appb-I000045
[화합물 79] [화합물 80][Compound 79] [Compound 80]
Figure PCTKR2018010549-appb-I000046
Figure PCTKR2018010549-appb-I000046
[화합물 81] [화합물 82][Compound 81] [Compound 82]
Figure PCTKR2018010549-appb-I000047
Figure PCTKR2018010549-appb-I000047
[화합물 83] [화합물 84][Compound 83] [Compound 84]
Figure PCTKR2018010549-appb-I000048
Figure PCTKR2018010549-appb-I000048
[화합물 85] [화합물 86][Compound 85] [Compound 86]
Figure PCTKR2018010549-appb-I000049
Figure PCTKR2018010549-appb-I000049
[화합물 87] [화합물 88][Compound 87] [Compound 88]
Figure PCTKR2018010549-appb-I000050
Figure PCTKR2018010549-appb-I000050
[화합물 89] [화합물 90][Compound 89] [Compound 90]
Figure PCTKR2018010549-appb-I000051
Figure PCTKR2018010549-appb-I000051
[화합물 91] [화합물 92][Compound 91] [Compound 92]
Figure PCTKR2018010549-appb-I000052
Figure PCTKR2018010549-appb-I000052
[화합물 93] [화합물 94][Compound 93] [Compound 94]
Figure PCTKR2018010549-appb-I000053
Figure PCTKR2018010549-appb-I000053
[화합물 95] [화합물 96][Compound 95] [Compound 96]
Figure PCTKR2018010549-appb-I000054
Figure PCTKR2018010549-appb-I000054
[화합물 97] [화합물 98][Compound 97] [Compound 98]
Figure PCTKR2018010549-appb-I000055
Figure PCTKR2018010549-appb-I000055
[화합물 99] [화합물 100][Compound 99] [Compound 100]
Figure PCTKR2018010549-appb-I000056
Figure PCTKR2018010549-appb-I000056
[화합물 101] [화합물 102][Compound 101] [Compound 102]
Figure PCTKR2018010549-appb-I000057
Figure PCTKR2018010549-appb-I000057
[화합물 103] [화합물 104][Compound 103] [Compound 104]
Figure PCTKR2018010549-appb-I000058
Figure PCTKR2018010549-appb-I000058
[화합물 105] [화합물 106][Compound 105] [Compound 106]
Figure PCTKR2018010549-appb-I000059
Figure PCTKR2018010549-appb-I000059
[화합물 107] [화합물 108][Compound 107] [Compound 108]
Figure PCTKR2018010549-appb-I000060
Figure PCTKR2018010549-appb-I000060
[화합물 109] [화합물 110][Compound 109] [Compound 110]
Figure PCTKR2018010549-appb-I000061
Figure PCTKR2018010549-appb-I000061
[화합물 111] [화합물 112][Compound 111] [Compound 112]
Figure PCTKR2018010549-appb-I000062
Figure PCTKR2018010549-appb-I000062
[화합물 113] [화합물 114][Compound 113] [Compound 114]
Figure PCTKR2018010549-appb-I000063
Figure PCTKR2018010549-appb-I000063
[화합물 115] [화합물 116][Compound 115] [Compound 116]
Figure PCTKR2018010549-appb-I000064
Figure PCTKR2018010549-appb-I000064
[화합물 117] [화합물 118][Compound 117] [Compound 118]
Figure PCTKR2018010549-appb-I000065
Figure PCTKR2018010549-appb-I000065
[화합물 119] [화합물 120][Compound 119] [Compound 120]
Figure PCTKR2018010549-appb-I000066
Figure PCTKR2018010549-appb-I000066
[화합물 121] [화합물 122][Compound 121] [Compound 122]
Figure PCTKR2018010549-appb-I000067
Figure PCTKR2018010549-appb-I000067
[화합물 123] [화합물 124][Compound 123] [Compound 124]
Figure PCTKR2018010549-appb-I000068
Figure PCTKR2018010549-appb-I000068
[화합물 125] [화합물 126] [Compound 125] [Compound 126]
Figure PCTKR2018010549-appb-I000069
Figure PCTKR2018010549-appb-I000069
[화합물 127] [화합물 128][Compound 127] [Compound 128]
Figure PCTKR2018010549-appb-I000070
Figure PCTKR2018010549-appb-I000070
[화합물 129] [화합물 130][Compound 129] [Compound 130]
Figure PCTKR2018010549-appb-I000071
Figure PCTKR2018010549-appb-I000071
[화합물 131] [화합물 132][Compound 131] [Compound 132]
Figure PCTKR2018010549-appb-I000072
Figure PCTKR2018010549-appb-I000072
[화합물 133] [화합물 134][Compound 133] [Compound 134]
한편, 본 발명은 상기 [화학식 A] 내지 [화학식 C]중 어느 하나로 표시되는 화합물을 포함하는 감광성 조성물을 제공한다.On the other hand, the present invention provides a photosensitive composition comprising a compound represented by any one of the above-mentioned formulas (A) to (C).
즉, 본 발명에 따른 상기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물은 광반응성 조성물내에 광가교성 모노머로서 포함되어 UV 등과 같은 광에 의해 박막 또는 프리즘 등을 형성할 수 있고, 상기 조성물을 디스플레이용이나 전자재료용 조성물에 사용하는 경우에 용매나 아크릴 모노머와의 상용성이 우수한 효과가 있다.That is, the compound represented by any one of the above-mentioned formulas (A) to (C) according to the present invention may be contained in the photoreactive composition as a photocrosslinkable monomer to form a thin film or a prism by light such as UV, When the composition is used in a composition for a display or an electronic material, it has an excellent compatibility with a solvent or an acrylic monomer.
또한, 상기 [화학식 A] 내지 [화학식 C]중 어느 하나로 표시되는 화합물은 굴절율, 투과도 및 내황변 특성이 우수하여 TFT-LCD용 및 OLED용 고굴절 모노머로 사용시 휘도 및 성능을 향상시킬 수 있다.The compounds represented by any one of the above-mentioned formulas (A) to (C) are excellent in refractive index, transmittance and yellowing resistance and can improve brightness and performance when used as a high refractive index monomer for TFT-LCD and OLED.
한편, 상기 감광성 조성물은 광개시제 또는 광중합성 모노머를 추가적으로 포함할 수 있으며, 이에 제한되지 않고 기타 공지의 감광성 조성물에 사용되는 물질을 추가적으로 포함할 수 있다.Meanwhile, the photosensitive composition may further include a photoinitiator or a photopolymerizable monomer, and may include, but not limited to, a substance used in other known photosensitive compositions.
또한, 본 발명은 상기 감광성 조성물을 중합하여 얻어지는 광학 물품을 제공한다.The present invention also provides an optical article obtained by polymerizing the photosensitive composition.
본 발명의 상기 감광성 조성물의 일 실시예로서, 조성물 100 중량부에 대해서, 상기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물 1 내지 95 중량부, 광중합성 화합물 0 내지 90 중량부 및 광개시제 0.1 내지 20 중량부를 함유할 수 있다.In one embodiment of the photosensitive composition of the present invention, 1 to 95 parts by weight of a compound represented by any one of the above formulas (A) to (C), 0 to 90 parts by weight of a photopolymerizable compound and 0.1 to 20 parts by weight of a photoinitiator.
여기서, 상기 광중합성 화합물은 한개 혹은 두개 이상의 아크릴기, 메타아크릴기 또는 비닐기를 포함한 화합물로서, 본 발명에 따른 광개시제가 UV에 의하여 라디칼이 생성되고 생성된 라디칼에 의해 가교가 되는 화합물을 의미한다. 상기 광중합성 화합물은 헥실(메타)아크릴레이트, 시클로헥실(메타)아크릴레이트, 테트라데실(메타)아크릴레이트 및 헥사데실(메타)아크릴레이트 등의 알킬아크릴레이트 또는; 알킬메타아크릴레이트, 에틸렌글리콜디(메타)아크릴레이트, 펜타에리스리톨트리(메타)아크릴레이트, 펜타에리스리톨테트라(메타)아크릴레이트, 펜타에리스리톨펜타(메타)아크릴레이트, 디펜타에리스리톨헥사(메타)아크릴레이트, 트리메틸올프로판디(메타)아크릴레이트, 트리메틸올프로판트리(메타)아크릴레이트, 펜타에리스리톨트리(메타)아크릴레이트, 아크릴산, 메타아크릴산, 글리시딜아크릴레이트, 스틸렌으로 이루어진 군으로부터 선택된 어느 하나 이상일 수 있다.Here, the photopolymerizable compound means a compound containing one or two or more acryl groups, methacrylic groups or vinyl groups, and the photoinitiator according to the present invention is a compound which is formed by radicals generated by UV and crosslinked by the generated radicals. The photopolymerizable compound may be an alkyl acrylate such as hexyl (meth) acrylate, cyclohexyl (meth) acrylate, tetradecyl (meth) acrylate and hexadecyl (meth) acrylate; (Meth) acrylate, pentaerythritol tetra (meth) acrylate, pentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, (Meth) acrylate, trimethylol propane di (meth) acrylate, trimethylol propane tri (meth) acrylate, pentaerythritol tri (meth) acrylate, acrylic acid, methacrylic acid, glycidyl acrylate, .
또한, 광개시제로는 케톤류, 케토아세탈류, 치오잔톤류, 포스핀옥사이드류, 안트라퀴논류, 트리클로로메틸 트리아진류, 옥심에스테르류 등을 사용할 수 있으며, 이러한 광개시제의 구체적인 예로는 페닐비페닐케톤, 치오잔톤(thioxanthone), 이소프로필치오잔톤, 디에틸치오잔톤, 벤조페논, 1-벤질-1-디메틸아미노-1-(4-모폴리노-벤조일)프로판, 1-히드록시-1-벤조일시클로헥산, 2-모폴릴-2-(4-메틸머캅토) 벤조일프로판, 에틸안트라퀴논, 4-벤조일-4-메틸디페닐설파이드, 벤조인부틸에테르, 2-히드록시-2-벤조일프로판, 2-히드록시-2-(4-이소프로필)벤조일프로판, 4-부틸벤조일트리클로로메탄, 4-페녹시벤조일디클로로메탄, 디페닐-2,4,6-트리메틸벤조일포스핀옥사이드, 벤조일포름산메틸, 1,7-비스(9-아크리디닐)헵탄, 2-메틸-4,6-비스 (트리클로로메틸)-s-트리아진, 2-페닐-4,6-비스(트리클로로메틸)-s-트리아진, 2-나프틸-4,6-비스 (트리클로로메틸)-s-트리아진, 1-[9-에틸-6-(2-메틸벤조일)-9H-카바졸-3-일]-에타논-1-(O-아세틸옥심), 1-(o-아세틸옥심)-1-[9-에틸-6-(2-메틸벤조일)-9H-카르바졸-3-일]에탄온, 2-(o-벤조일옥심)-1-[4-(페닐티오)페닐]-1,2-옥탄디온 군으로부터 선택된 어느 하나 이상을 포함할 수 있다.Examples of the photoinitiator include ketones, ketoacetals, thioguanthones, phosphine oxides, anthraquinones, trichloromethyl triazine, and oxime esters. Specific examples of such photo initiators include phenylbiphenyl ketone, 1-benzyl-1-dimethylamino-1- (4-morpholino-benzoyl) propane, 1-hydroxy-1-benzoylcyclopentane, Benzoyl-4-methylphenyl sulfide, benzoin butyl ether, 2-hydroxy-2-benzoyl propane, 2-methyl- Butylbenzoyl trichloromethane, 4-phenoxybenzoyl dichloromethane, diphenyl-2,4,6-trimethylbenzoylphosphine oxide, methyl benzoylformate, methyl benzoate, (Trichloromethyl) -s-triazine, 2-methyl-4,6-bis (trichloromethyl) Naphthyl-4,6-bis (trichloromethyl) -s-triazine, 1- [9-ethyl-6- (2 -Methylbenzoyl) -9H-carbazol-3-yl] -ethanone- 1- (O-acetyloxime), 1- ) -9H-carbazol-3-yl] ethanone, and 2- (o-benzoyloxime) -1- [4- (phenylthio) phenyl] .
이러한 광개시제는 보다 바람직하게는, 노광 감도와 패턴 특성을 조절하기 위하여 감광성 조성물 100중량부를 기준으로 0.1 내지 20중량부를 사용하며, 바람직하게는 0.1 내지 10중량부를 사용할 수 있다.Such a photoinitiator is more preferably used in an amount of 0.1 to 20 parts by weight, preferably 0.1 to 10 parts by weight, based on 100 parts by weight of the photosensitive composition, in order to control exposure sensitivity and pattern characteristics.
또한, 상기 감광성 조성물을 용해하는데 선택적으로 유기용매가 사용될 수 있으며, 점도 조절과 코팅 특성 개선을 위해 사용되며, 이러한 용매로는 유기용매를 사용하는 것이 바람직하다.In addition, an organic solvent may optionally be used to dissolve the photosensitive composition, Is used for improving the coating property, and it is preferable to use an organic solvent as such solvent.
상기 유기용매로서, 바람직하게는 에틸아세테이트, 부틸아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디메틸에틸에테르, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트(EEP), 에틸락테이트, 프로필렌글리콜메틸에테르아세테이트(PGMEA), 프로필렌글리콜메틸에테르, 프로필렌글리콜프로필에테르, 메틸셀로솔브아세테이트, 에틸셀로솔브아세테이트, 디에틸렌글리콜메틸아세테이트, 디에틸렌글리콜에틸아세테이트, 아세톤, 메틸이소부틸케톤, 시클로헥사논, 디메틸포름아미드(DMF), N,N-디메틸아세트아미드(DMAc), N-메틸-2-피롤리돈(NMP), γ-부티로락톤, 디에틸에테르, 에틸렌글리콜디메틸에테르, 다이글라임(Diglyme), 테트라하이드로퓨란(THF), 메탄올, 에탄올, 프로판올, 이소-프로판올, 메틸셀로솔브, 에틸셀로솔브, 디에틸렌글리콜메틸에테르, 디에틸렌글리콜에틸에테르, 디프로필렌글리콜메틸에테르, 톨루엔, 크실렌, 헥산, 헵탄 및 옥탄 중에서 선택된 1종 이상을 사용할 수 있으며, 여기서 상기 용매의 함량은 상기 감광성 조성물 100 중량부를 기준으로 0 내지 90 중량부를 포함하는 것이 바람직하다.As the organic solvent, preferably ethyl acetate, butyl acetate, diethylene glycol dimethyl ether, diethylene glycol dimethyl ethyl ether, methyl methoxy propionate, ethyl ethoxypropionate (EEP), ethyl lactate, propylene glycol Methyl ether acetate (PGMEA), propylene glycol methyl ether, propylene glycol propyl ether, methyl cellosolve acetate, ethyl cellosolve acetate, diethylene glycol methyl acetate, diethylene glycol ethyl acetate, acetone, methyl isobutyl ketone, (NMP), gamma -butyrolactone, diethyl ether, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol dimethyl ether The reaction conditions are as follows: Diglyme, tetrahydrofuran (THF), methanol, ethanol, propanol, iso-propanol, methyl cellosolve, ethyl cellosolve, The solvent may be used in an amount of from 0 to 90% by weight, based on 100 parts by weight of the photosensitive composition, of at least one member selected from the group consisting of methyl ethyl ketone, diethyleneglycol ethyl ether, dipropylene glycol methyl ether, toluene, xylene, hexane, By weight.
또한, 본 발명에 따른 감광성 조성물은 프리즘시트, 마이크로렌즈, LCD용 코팅 재료, DBEF 필름, 유기발광소자(OLED)용 코팅 재료, 광학렌즈, 다초점렌즈 중에서 선택되는 어느 하나를 제조하기 위해 사용될 수 있다. Further, the photosensitive composition according to the present invention can be used for producing any one selected from a prism sheet, a microlens, a coating material for LCD, a DBEF film, a coating material for an organic light emitting diode (OLED) have.
이하, 바람직한 실시예를 들어 본 발명을 더욱 상세하게 설명한다. 그러나, 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이에 의하여 제한되지 않는다는 것은 당업계의 통상의 지식을 가진 자에게 자명할 것이다. Hereinafter, the present invention will be described in more detail with reference to preferred embodiments. It will be apparent, however, to those skilled in the art that these embodiments are for further explanation of the present invention and that the scope of the present invention is not limited thereby.
상기 [화학식 A], [화학식 B] 및 [화학식 C] 중 어느 하나로 표시되는 아크릴기를 포함하는 화합물을 합성하는 대표적인 방법에 대하여 예시하면, 하기 반응식 1과 같다. Representative methods for synthesizing the compound having an acrylic group represented by any one of the above-mentioned [Chemical Formulas A], [Chemical Formula B] and [Chemical Formula C] are shown in the following Reaction Scheme 1.
[반응식 1] [Reaction Scheme 1]
Figure PCTKR2018010549-appb-I000073
Figure PCTKR2018010549-appb-I000073
상기 반응식 1은 상기 아크릴기를 포함하는 화합물 중 일부에 대한 합성 메커니즘을 나타낸 것이며, 적절히 치환기를 변경하여 상기 [화학식 A], [화학식 B] 및 [화학식 C] 중 어느 하나로 표시되는 다양한 아크릴기를 포함하는 화합물을 합성할 수 있다.The reaction scheme 1 shows a synthetic mechanism for a part of the compounds having an acryl group and may be appropriately substituted with a substituent such that the substituent is appropriately substituted with a substituent selected from the group consisting of a variety of acrylic groups represented by any one of the formulas (A), (B) Compounds can be synthesized.
합성예 1: 화합물 2의 제조 Synthesis Example 1: Preparation of Compound 2
Figure PCTKR2018010549-appb-I000074
Figure PCTKR2018010549-appb-I000074
합성예 1-1. 3,3',3''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl)) triphenol의 제조Synthesis Example 1-1. Preparation of 3,3 ', 3' '- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl)) triphenol
1L 반응기에 THF 300 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 20.0 g(108.5 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 3-aminophenol 35.5 g(325.4 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate Molecular Weight: 82.03 20.0 g(244.0mmol)을 가한다. 반응용기를 80oC로 가열하여 10시간 동안 교반한다. 반응종료 후 증류수 300ml를 첨가하고 교반하여 흰색 고체 3,3',3''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))triphenol 40.1g (수율 92%)을 제조하였다.300 ml of THF is added to a 1 L reactor, and 20.0 g (108.5 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 35.5 g (325.4 mmol) of 3-aminophenol is added slowly with stirring for 30 minutes, then 20.0 g (244.0 mmol) of sodium acetate Molecular Weight: 82.03 is added. The reaction vessel is heated to 80 ° C and stirred for 10 hours. After completion of the reaction, 300 ml of distilled water was added and stirred to obtain 40.1 g (yield: 92%) of a solid white 3,3 ', 3''- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl) %).
합성예 1-2. 화합물 2의 제조Synthesis Example 1-2. Preparation of Compound 2
250ml 반응기에 THF 100mL, Triethylamine 30ml 및 3,3',3''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))triphenol 10.0 g (24.9 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 4.5g(49.7mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 2] 11.5 g (수율 91%)을 제조하였다.A 250 ml reactor was charged with 100 ml of THF, 30 ml of triethylamine and 10.0 g (24.9 mmol) of 3,3 ', 3''- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl) And cooled to 0 ° C under nitrogen. 4.5 g (49.7 mmol) of acryloyl chloride is slowly added to the above reaction vessel for 30 minutes, followed by stirring at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . After concentration under reduced pressure, column purification was carried out with ethyl acetate: hexane = 1: 3 to obtain 11.5 g (yield 91%) of [Compound 2].
합성예 2: 화합물 4의 제조 Synthesis Example 2: Preparation of Compound 4
Figure PCTKR2018010549-appb-I000075
Figure PCTKR2018010549-appb-I000075
합성예 2-1. 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl)) triphenol의 제조Synthesis Example 2-1. Preparation of 4,4 ', 4' '- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl)) triphenol
1L 반응기에 THF 250 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 15.0 g(81.3 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 4-aminophenol 26.6 g(244.0 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 20.0 g(244.0mmol)을 가한다. 반응용기를 80oC로 가열하여 10시간 동안 교반한다. 반응종료 후 증류수 250ml를 첨가하고 교반하여 흰색 고체 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))triphenol 30.8g (수율 94%)을 제조하였다.In a 1 L reactor, 250 ml of THF is added, and 15.0 g (81.3 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 26.6 g (244.0 mmol) of 4-aminophenol is added slowly with stirring for 30 minutes, then 20.0 g (244.0 mmol) of sodium acetate is added. The reaction vessel is heated to 80 ° C and stirred for 10 hours. After completion of the reaction, 250 ml of distilled water was added and stirred to obtain 30.8 g of white solid 4,4 ', 4''- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl) %).
합성예 2-2. 화합물 4의 제조Synthesis Example 2-2. Preparation of compound 4
250ml 반응기에 THF 100mL, Triethylamine 30ml 및 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))triphenol 10.0 g (24.9 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 7.4g(82.2mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 4] 12.5 g (수율 89%)을 제조하였다.A 250 ml reactor was charged with 100 ml of THF, 30 ml of triethylamine and 10.0 g (24.9 mmol) of 4,4 ', 4''- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl) And cooled to 0 ° C under nitrogen. 7.4 g (82.2 mmol) of acryloyl chloride is slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure, and then subjected to column purification with ethyl acetate: hexane = 1: 3 to obtain 12.5 g (yield 89%) of [Compound 4].
합성예 3: 화합물 12의 제조 Synthesis Example 3: Preparation of Compound 12
Figure PCTKR2018010549-appb-I000076
Figure PCTKR2018010549-appb-I000076
합성예 3-1. 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(methylazanediyl)) triphenol의 제조Synthesis Example 3-1. Preparation of 4,4 ', 4' '- ((1,3,5-triazine-2,4,6-triyl) tris (methylazanediyl) triphenol
500 mL 반응기에 THF 150 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 10.0 g(54.2 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 4-(methylamino)phenol 20.0 g(162,6 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 13.3 g(244.0 mmol)을 가한다. 반응용기를 80oC로 가열하여 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(methylazanediyl))triphenol 21.7g (수율 90%)을 제조하였다.In a 500 mL reactor, 150 mL of THF is added, and 10.0 g (54.2 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 20.0 g (162.6 mmol) of 4- (methylamino) phenol is added slowly with stirring for 30 minutes, then 13.3 g (244.0 mmol) of sodium acetate are added. The reaction vessel is heated to 80 ° C and stirred for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain 21.7 g of white solid 4,4 ', 4''- ((1,3,5-triazine-2,4,6-triyl) tris (methylazanediyl) %).
합성예 3-2. 화합물 12의 제조Synthesis Example 3-2. Preparation of Compound 12
250ml 반응기에 THF 120mL, Triethylamine 20ml 및 4,4',4''-((1,3,5-triazine-2,4,6-triyl)tris(methylazanediyl))triphenol 12.0 g (27.0 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 2.4g(27.0mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 12] 10.4 g (수율 93%)을 제조하였다.120 ml of THF, 20 ml of triethylamine and 12.0 g (27.0 mmol) of 4,4 ', 4''- ((1,3,5-triazine-2,4,6-triyl) tris (methylazanediyl) And cooled to 0 ° C under nitrogen. 2.4 g (27.0 mmol) of acryloyl chloride is slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . After concentration under reduced pressure, column purification was carried out with ethyl acetate: hexane = 1: 3 to obtain 10.4 g (yield 93%) of [Compound 12].
합성예 4: 화합물 25의 제조Synthesis Example 4: Preparation of Compound 25
Figure PCTKR2018010549-appb-I000077
Figure PCTKR2018010549-appb-I000077
합성예 4-1. 3,3',3''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl)) triphenol의 제조Synthesis Example 4-1. Preparation of 3,3 ', 3' '- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl)) triphenol
합성예 1-1과 동일한 방법으로 제조하였다.Was prepared in the same manner as in Synthesis Example 1-1.
합성예 4-2. 2,2',2''-((((1,3,5-triazine-2,4,6-triyl)tris(azanediyl)) tris(benzene-3,1-diyl))tris(oxy))triethanol의 제조Synthesis Example 4-2. 2,2 ', 2' - (((1,3,5-triazine-2,4,6-triyl) tris (azaneediyl) tris (benzene-3,1- Preparation of triethanol
250 mL 반응기에 DMF 100 ml를 넣고 질소분위기 하에서 3,3',3''-((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))triphenol 10 g (24.9 mmol)과 K2CO3 10.3g(74.7mmol)을 가한다. 위 반응기에 2-bromoethanol 11.2g(89.5mmol)을 30분간 천천히 가한 후 80oC에서 10시간 동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출하여 유기물을 분리한 후 에틸아세테이트 층을 증류수로 2회 세척한다. 유기층을 MgSO4를 사용하여 수분을 제거하고, 감압 농축하여 흰색 고체 2,2',2''-((((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tris(benzene-3,1-diyl))tris (oxy))triethanol 12.8g (수율 96%)을 제조하였다.To a 250 mL reactor was added 100 mL of DMF and 10 g (24.9 mmol) of 3,3 ', 3''- ((1,3,5-triazine-2,4,6-triyl) tris (azanediyl)) triphenol ) And 10.3 g (74.7 mmol) of K 2 CO 3 are added. 11.2 g (89.5 mmol) of 2-bromoethanol was slowly added to the reactor for 30 minutes, followed by stirring at 80 ° C for 10 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was separated. The ethyl acetate layer was washed twice with distilled water. The organic layer was dried over MgSO 4 and concentrated under reduced pressure to obtain a white solids 2,2 ', 2 "- ((((1,3,5-triazine-2,4,6-triyl) tris (azanediyl) ) tris (benzene-3,1-diyl)) tris (oxy)) triethanol (yield: 96%).
합성예 4-3. 화합물 25의 제조Synthesis Example 4-3. Preparation of Compound 25
500ml 반응기에 THF 200mL, Triethylamine 20ml 및 2,2',2''-((((1,3,5-triazine-2,4,6-triyl)tris(azanediyl))tris(benzene-3,1-diyl))tris(oxy)) triethanol 20.0 g (37.4 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 10.2g(112.2 mmol)을 30분 동안 천천히 가한 후 상온에서 15시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 4로 컬럼 정제하여 [화합물 25] 22.2 g (수율 85%)을 제조하였다.To a 500 ml reactor were added 200 ml of THF, 20 ml of triethylamine and 20 ml of 2,2 ', 2''- (((1,3,5-triazine-2,4,6-triyl) tris (azene) -diyl)) tris (oxy)) triethanol (20.0 g, 37.4 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 10.2 g (112.2 mmol) of acryloyl chloride is slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 15 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . After concentration under reduced pressure, the residue was subjected to column purification with ethyl acetate: hexane = 1: 4 to obtain 22.2 g (yield 85%) of [Compound 25].
합성예 5: 화합물 40의 제조Synthesis Example 5: Preparation of Compound 40
Figure PCTKR2018010549-appb-I000078
Figure PCTKR2018010549-appb-I000078
합성예 5-1. 3,3'-((6-(phenylamino)-1,3,5-triazine-2,4-diyl)bis (azanediyl))diphenol의 제조Synthesis Example 5-1. Preparation of 3,3 '- ((6- (phenylamino) -1,3,5-triazine-2,4-diyl) bis (azanediyl) diphenol
500 mL 반응기에 THF 120 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 12.0 g(65.1 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 3-aminophenol 14.2 g(130.2 mmol)과 4-methoxyaniline 8.0g(65.1mmol)을 교반하면서 각각 30분 동안 천천히 순차적으로 가한 후 sodium acetate 16.0 g(195.3mmol)을 가한다. 반응용기를 80oC로 가열하여 10시간 동안 교반한다. 반응종료 후 증류수 120ml를 첨가하고 교반하여 흰색 고체 3,3'-((6-((4-methoxyphenyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))diphenol 22.8g (수율 84%)을 제조하였다.120 mL of THF is added to a 500 mL reactor, and 12.0 g (65.1 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 14.2 g (130.2 mmol) of 3-aminophenol and 8.0 g (65.1 mmol) of 4-methoxyaniline were slowly added in succession for 30 minutes each with stirring. 16.0 g (195.3 mmol) . The reaction vessel is heated to 80 ° C and stirred for 10 hours. After completion of the reaction, 120 ml of distilled water was added and stirred to obtain white solid 3,3 '- ((6 - ((4-methoxyphenyl) amino) -1,3,5-triazine-2,4-diyl) bis (azanediyl) (Yield: 84%).
합성예 5-2. 화합물 40의 제조Synthesis Example 5-2. Preparation of Compound 40
250ml 반응기에 THF 100mL, Triethylamine 20ml 및 3,3'-((6-((4-methoxyphenyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl))diphenol 8.0 g (19.2 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 methacryloyl chloride 4.0g(38.4mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1 : 5로 컬럼 정제하여 [화합물 40] 10.4 g (수율 90%)을 제조하였다.To a 250 ml reactor were added 100 ml of THF, 20 ml of triethylamine and 8.0 g of 3,3 '- ((6 - ((4-methoxyphenyl) amino) -1,3,5-triazine-2,4-diyl bis azanediyl) diphenol 19.2 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 4.0 g (38.4 mmol) of methacryloyl chloride is slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure and then subjected to column purification with ethyl acetate: hexane = 1: 5 to obtain 10.4 g (yield 90%) of [Compound 40].
합성예 6: 화합물 81의 제조Synthesis Example 6: Preparation of Compound 81
Figure PCTKR2018010549-appb-I000079
Figure PCTKR2018010549-appb-I000079
합성예 6-1. 2,2'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis (sulfanediyl))diethanol의 제조Synthesis Example 6-1. Preparation of 2,2 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4-diyl) bis (sulfanediyl)) diethanol
500 mL 반응기에 THF 150 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 15.0 g(81.3 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 2-aminoethanol 5.0 g(81.3 mmol)과 2-mercaptoethanol 12.7g(162.6 mmol)을 교반하면서 각각 30분 동안 천천히 순차적으로 가한 후 sodium acetate 20.0 g(243.9 mmol)을 가한다. 반응용기를 80oC로 가열하여 15시간 동안 교반한다. 반응종료 후 증류수와 에틸아세테이트를 첨가하고 축출한다. 유기층을 증류수로 세척한 후 MgSO4를 첨가하여 수분을 제거한 후 용매를 날린다. EA와 헥산 1 : 3에서 컬럼 분리하여 2,2'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl)) diethanol 18.6g (수율 78%)을 제조하였다.150 mL of THF is added to a 500 mL reactor, and 15.0 g (81.3 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.0 g (81.3 mmol) of 2-aminoethanol and 12.7 g (162.6 mmol) of 2-mercaptoethanol were slowly added in succession for 30 min each time with stirring, and 20.0 g (243.9 mmol) . The reaction vessel is heated to 80 ° C and stirred for 15 hours. After the completion of the reaction, distilled water and ethyl acetate are added and removed. After the organic layer is washed with distilled water, MgSO 4 is added to remove moisture, and then the solvent is removed. Diethanol was obtained by separating the column from EA and hexane 1: 3 to obtain 18.6 g of 2,2 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine- (Yield: 78%).
합성예 6-2. 화합물 81의 제조Synthesis Example 6-2. Preparation of Compound 81
250ml 반응기에 THF 120mL, Triethylamine 30ml 및 2,2'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))diethanol 12.0 g (41.0 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 11.1 g(123.1 mmol)을 30분 동안 천천히 가한 후 상온에서 10시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1 : 5로 컬럼 정제하여 [화합물 81] 17.2 g (수율 92%)을 제조하였다.To a 250 ml reactor were added 120 ml of THF, 30 ml of triethylamine and 12.0 g of (2 - ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4-diyl bis (sulfanediyl) 41.0 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. Add 11.1 g (123.1 mmol) of acryloyl chloride to the above reaction vessel slowly for 30 minutes, and then stir at room temperature for 10 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure, and then subjected to column purification using ethyl acetate: hexane = 1: 5 to obtain 17.2 g (yield 92%) of [Compound 81].
합성예 7: 화합물 83의 제조Synthesis Example 7: Preparation of Compound 83
Figure PCTKR2018010549-appb-I000080
Figure PCTKR2018010549-appb-I000080
합성예 7-1. 2,2'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(oxy))diethanol 의 제조Synthesis Example 7-1. Preparation of 2,2 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4-diyl) bis (oxy)) diethanol
500 mL 반응기에 THF 150 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 15.0g (81.3 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 2-aminoethanol 5.0g (81.3 mmol)과 ethane-1,2-diol 10.0g (162.6 mmol)을 교반하면서 각각 30분 동안 천천히 순차적으로 가한 후 sodium acetate 20.0g (244.0mmol)을 가한다. 반응용기를 80oC로 가열하여 15시간 동안 교반한다. 반응종료 후 증류수와 에틸아세테이트를 첨가하고 축출한다. 유기층을 증류수로 세척한 후 MgSO4를 첨가하여 수분을 제거한 후 용매를 날린다. EA와 헥산 1 : 3에서 컬럼 분리하여 2,2'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(oxy))diethanol 16g (수율 76%)을 제조하였다.150 mL of THF is added to a 500 mL reactor, and 15.0 g (81.3 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.0 g (81.3 mmol) of 2-aminoethanol and 10.0 g (162.6 mmol) of ethane-1,2-diol were slowly added for 30 min each time with stirring. 244.0 mmol) is added. The reaction vessel is heated to 80 ° C and stirred for 15 hours. After the completion of the reaction, distilled water and ethyl acetate are added and removed. After the organic layer is washed with distilled water, MgSO 4 is added to remove moisture, and then the solvent is removed. The reaction mixture was separated by column chromatography with EA and hexane 1: 3 to obtain 16 g of 2,2 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4- Yield: 76%).
합성예 7-2. 화합물 83의 제조Synthesis Example 7-2. Preparation of Compound 83
250ml 반응기에 THF 100mL, Triethylamine 30ml 및 2,2'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(oxy))diethanol 10.0g (38.4 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 10.4g (115.2 mmol)을 30분 동안 천천히 가한 후 상온에서 10시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1 : 5로 컬럼 정제하여 [화합물 83] 15.2g (수율 94%)을 제조하였다.To a 250 ml reactor were added 100 ml of THF, 30 ml of triethylamine and 10.0 g of 2,2 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine- 38.4 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 10.4 g (115.2 mmol) of acryloyl chloride is slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 10 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The solvent was distilled off under reduced pressure, and the residue was purified by column chromatography with ethyl acetate: hexane = 1: 5 to obtain 15.2 g (yield 94%) of [Compound 83].
합성예 8: 화합물 85의 제조 Synthesis Example 8: Preparation of Compound 85
Figure PCTKR2018010549-appb-I000081
Figure PCTKR2018010549-appb-I000081
합성예 8-1. 2,2'-((6-((2-hydroxyethyl)thio)-1,3,5-triazine-2,4-diyl)bis(methylazanediyl))diethanol 의 제조Synthesis Example 8-1. Preparation of 2,2 '- ((6 - ((2-hydroxyethyl) thio) -1,3,5-triazine-2,4-diyl) bis (methylazanediyl)) diethanol
500 mL 반응기에 THF 150 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 15.0g (81.3 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 2-mercaptoethanol 6.3g (81.3 mmol) 과 2-(methylamino)ethanol 12.2g (162.6 mmol)을 교반하면서 각각 30분 동안 천천히 순차적으로 가한 후 sodium acetate 20.0g (244.0mmol)을 가한다. 반응용기를 80oC로 가열하여 15시간 동안 교반한다. 반응종료 후 증류수와 에틸아세테이트를 첨가하고 축출한다. 유기층을 증류수로 세척한 후 MgSO4를 첨가하여 수분을 제거한 후 용매를 날린다. EA와 헥산 1 : 3에서 컬럼 분리하여 2,2'-((6-((2-hydroxyethyl)thio)-1,3,5-triazine-2,4-diyl)bis(methylazanediyl))diethanol 19.0g (수율 77%)을 제조하였다.150 mL of THF is added to a 500 mL reactor, and 15.0 g (81.3 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 6.3 g (81.3 mmol) of 2-mercaptoethanol and 12.2 g (162.6 mmol) of 2- (methylamino) ethanol were slowly added sequentially with stirring for 30 minutes each. mmol). The reaction vessel is heated to 80 ° C and stirred for 15 hours. After the completion of the reaction, distilled water and ethyl acetate are added and removed. After the organic layer is washed with distilled water, MgSO 4 is added to remove moisture, and then the solvent is removed. Diethanol was obtained by separating the column from EA and hexane 1: 3 to obtain 19.0 g of 2,2 '- ((6 - ((2-hydroxyethyl) thio) -1,3,5-triazine-2,4-diyl) bis (methylazanediyl) (Yield: 77%).
합성예 8-2. 화합물 85의 제조Synthesis Example 8-2. Preparation of Compound 85
250ml 반응기에 THF 100mL, Triethylamine 20ml 및 2,2'-((6-((2-hydroxyethyl)thio)-1,3,5-triazine-2,4-diyl)bis(methylazanediyl))diethanol 10.0 g (32.9 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 methacryloyl chloride 10.3g (98.8 mmol)을 30분 동안 천천히 가한 후 상온에서 10시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1 : 5로 컬럼 정제하여 [화합물 85] 15.0g (수율 90%)을 제조하였다.A 250 ml reactor was charged with 100 ml of THF, 20 ml of triethylamine and 10.0 g of 2,2 '- ((6 - ((2-hydroxyethyl) thio) -1,3,5-triazine-2,4-diyl) bis (methylazanediyl) 32.9 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 10.3 g (98.8 mmol) of methacryloyl chloride was slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 10 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The reaction mixture was concentrated under reduced pressure, and then subjected to column purification with ethyl acetate: hexane = 1: 5 to obtain 15.0 g (yield: 90%) of [Compound 85].
합성예 9: 화합물 99의 제조Synthesis Example 9: Preparation of Compound 99
Figure PCTKR2018010549-appb-I000082
Figure PCTKR2018010549-appb-I000082
합성예 9-1. 3,3'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))diphenol 의 제조Synthesis Example 9-1. Preparation of 3,3 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4-diyl) bis (sulfanediyl) diphenol
500 mL 반응기에 THF 150 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 15.0 g (81.3 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 2-aminoethanol 4.9 g (81.3 mmol) 과 3-mercaptophenol 20.5g (162.6 mmol)을 교반하면서 각각 30분 동안 천천히 순차적으로 가한 후 sodium acetate 20.0 g (244.0mmol)을 가한다. 반응용기를 80oC로 가열하여 15시간 동안 교반한다. 반응종료 후 증류수와 에틸아세테이트를 첨가하고 축출한다. 유기층을 증류수로 세척한 후 MgSO4를 첨가하여 수분을 제거한 후 용매를 날린다. EA와 헥산 1 : 3에서 컬럼 분리하여 3,3'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))diphenol 23.0g (수율 73%)을 제조하였다.150 mL of THF is added to a 500 mL reactor, and 15.0 g (81.3 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 4.9 g (81.3 mmol) of 2-aminoethanol and 20.5 g (162.6 mmol) of 3-mercaptophenol were slowly added in succession for 30 minutes each time with stirring. 20.0 g (244.0 mmol) . The reaction vessel is heated to 80 ° C and stirred for 15 hours. After the completion of the reaction, distilled water and ethyl acetate are added and removed. After the organic layer is washed with distilled water, MgSO 4 is added to remove moisture, and then the solvent is removed. Diacetyl) diphenol) 23.0 g of 3,3 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine- (Yield: 73%).
합성예 9-2. 2,2'-((((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))bis(3,1-phenylene))bis(oxy))diethanol 의 제조Synthesis Example 9-2. Bis (3,1-phenylene)) bis ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4-diyl bis (sulfanediyl) oxy)) diethanol
250 mL 반응기에 DMF 100 ml를 넣고 질소분위기 하에서 3,3'-((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))diphenol 10.0g (25.7 mmol)과 K2CO3 7.1g (51.4 mmol)을 가한다. 위 반응기에 2-bromoethanol 6.4g (51.4mmol)을 30분간 천천히 가한 후 80oC에서 10시간 동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출하여 유기물을 분리한 후 에틸아세테이트 층을 증류수로 2회 세척한다. 유기층을 MgSO4를 사용하여 수분을 제거하고, 감압 농축하여 흰색 고체 2,2'-((((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))bis(3,1-phenylene))bis(oxy))diethanol 11.3g (수율 92%)을 제조하였다.To a 250 mL reactor, 100 mL of DMF was added, and 3,3 '- ((6 - ((2-hydroxyethyl) amino) -1,3,5-triazine-2,4-diyl) bis (sulfanediyl) diphenol 10.0 g (25.7 mmol) of K 2 CO 3 and 7.1 g (51.4 mmol) of K 2 CO 3 are added. 6.4 g (51.4 mmol) of 2-bromoethanol is slowly added to the reactor for 30 minutes and then stirred at 80 ° C for 10 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was separated. The ethyl acetate layer was washed twice with distilled water. The organic layer was dried over MgSO 4 , and concentrated under reduced pressure to give a white solid. 2 - ((((6- (2-hydroxyethyl) amino) -1,3,5-triazine- ) bis (sulfanediyl)) bis (3,1-phenylene)) bis (oxy)) diethanol.
합성예 9-3. 화합물 99의 제조Synthesis Example 9-3. Preparation of Compound 99
250ml 반응기에 THF 100mL, Triethylamine 20ml 및 2,2'-((((6-((2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(sulfanediyl))bis(3,1-phenylene))bis(oxy))diethanol 10.0g (20.9 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 5.7g (62.9 mmol)을 30분 동안 천천히 가한 후 상온에서 10시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1 : 4로 컬럼 정제하여 [화합물 99] 12.6g (수율 94%)을 제조하였다.To a 250 ml reactor were added 100 ml of THF, 20 ml of triethylamine and 20 ml of 2,2 '- (((6- (2-hydroxyethyl) amino) -1,3,5-triazine- 3,1-phenylene)) bis (oxy)) diethanol (10.0 g, 20.9 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 5.7 g (62.9 mmol) of acryloyl chloride was slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 10 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure and then subjected to column purification with ethyl acetate: hexane = 1: 4 to obtain 12.6 g (yield 94%) of [Compound 99].
합성예 10: 화합물 109의 제조 Synthesis Example 10: Preparation of Compound 109
Figure PCTKR2018010549-appb-I000083
Figure PCTKR2018010549-appb-I000083
합성예 10-1. 4,6-dichloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-phenyl-1,3,5-triazin-2-amine의 제조Synthesis Example 10-1. Preparation of 4,6-dichloro-N- (4,6-dichloro-1,3,5-triazin-2-yl) -N-phenyl-1,3,5-triazin-2-
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 20.0 g(108.5 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 aniline 5.0 g(54.2 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 17.8 g(216.9 mmol)을 가한다. 상온에서 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 4,6-dichloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-phenyl-1,3,5-triazin-2-amine 17.5g (수율 83%)을 제조하였다.200 mL of THF is added to a 500 mL reactor, and 20.0 g (108.5 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.0 g (54.2 mmol) of aniline was added slowly with stirring for 30 minutes, then 17.8 g (216.9 mmol) of sodium acetate was added. Stir at room temperature for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain a white solid 4,6-dichloro-N- (4,6-dichloro-1,3,5-triazin- triazin-2-amine (yield: 83%).
합성예 10-2. 4,4',4'',4'''-((6,6'-(phenylazanediyl)bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol의 제조Synthesis Example 10-2. Bis (1,3,5-triazine-6,4,2-triyl) tetrakis (azanediyl)) tetraphenol of the formula: 4,4 ', 4 ", 4" Produce
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 4,6-dichloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-phenyl-1,3,5-triazin-2-amine 17.5 g(45.0 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 4-aminophenol 19.7 g(180.0 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 14.8 g(180.0 mmol)을 가한다. 반응용기를 80℃까지 온도를 올린 후 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 4,4',4'',4'''-((6,6'-(phenylazanediyl)bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 27.8g (수율 91%)을 제조하였다.200 ml of THF was added to a 500 ml reactor and 4,6-dichloro-1,3,5-triazin-2-yl) -N-phenyl-1,3,5- triazin-2-amine (17.5 g, 45.0 mmol). After cooling the reaction flask to 0 ° C, 19.7 g (180.0 mmol) of 4-aminophenol was slowly added for 30 minutes while stirring, and 14.8 g (180.0 mmol) of sodium acetate was added thereto. The reaction vessel is heated to 80 < 0 > C and stirred for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain white solids 4,4 ', 4 ", 4"' - ((6,6 '- (phenylazanediyl) bis 2-triyl)) tetrakis (azanediyl)) tetraphenol (yield: 91%).
합성예 10-3. 화합물 109의 제조Synthesis Example 10-3. Preparation of Compound 109
500ml 반응기에 THF 200mL, 4,4',4'',4'''-((6,6'-(phenylazanediyl)bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 27.8 g (41.0 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 14.8g(163.8mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 109] 30.8 g (수율 84%)을 제조하였다.A 500 ml reactor was charged with 200 ml of THF, 4,4 ', 4'',4''' - ((6,6 '- (phenylazanediyl) bis (1,3,5-triazine-6,4,2- (azanediyl)) tetraphenol (27.8 g, 41.0 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 14.8 g (163.8 mmol) of acryloyl chloride is slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure, and then subjected to column purification with ethyl acetate: hexane = 1: 3 to obtain 30.8 g (yield: 84%) of [Compound 109].
합성예 11: 화합물 110의 제조Synthesis Example 11: Preparation of Compound 110
Figure PCTKR2018010549-appb-I000084
Figure PCTKR2018010549-appb-I000084
합성예 11-1. 4,6-dichloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-phenyl-1,3,5-triazin-2-amine의 제조Synthesis Example 11-1. Preparation of 4,6-dichloro-N- (4,6-dichloro-1,3,5-triazin-2-yl) -N-phenyl-1,3,5-triazin-2-
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 20.0 g(108.5 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 aniline 5.0 g(54.2 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 17.8 g(216.9 mmol)을 가한다. 상온에서 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 4,6-dichloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-phenyl-1,3,5-triazin-2-amine 17.1g (수율 81%)을 제조하였다.200 mL of THF is added to a 500 mL reactor, and 20.0 g (108.5 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.0 g (54.2 mmol) of aniline was added slowly with stirring for 30 minutes, then 17.8 g (216.9 mmol) of sodium acetate was added. Stir at room temperature for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain a white solid 4,6-dichloro-N- (4,6-dichloro-1,3,5-triazin- triazin-2-amine (yield 81%).
합성예 11-2. 3,3',3'',3'''-((6,6'-(phenylazanediyl)bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol의 제조Synthesis Example 11-2. 3,3 ', 3 ", 3' '- ((6,6' - (phenylazanediyl) bis (1,3,5-triazine-6,4,2-triyl) tetrakis (azanediyl) Produce
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 4,6-dichloro-N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-phenyl-1,3,5-triazin-2-amine 17.1 g(43.9 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 3-aminophenol 19.2 g(175.7 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 14.4 g(175.7 mmol)을 가한다. 반응용기를 80℃까지 온도를 올린 후 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 3,3',3'',3'''-((6,6'-(phenylazanediyl)bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 26.9g (수율 90%)을 제조하였다.200 ml of THF was added to a 500 ml reactor and 4,6-dichloro-1,3,5-triazin-2-yl) -N-phenyl-1,3,5- triazin-2-amine (17.1 g, 43.9 mmol). After cooling the reaction flask to 0 ° C, 19.2 g (175.7 mmol) of 3-aminophenol was slowly added over 30 minutes with stirring and 14.4 g (175.7 mmol) of sodium acetate was added. The reaction vessel is heated to 80 < 0 > C and stirred for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain white solid 3,3 ', 3'',3''' - ((6,6 '- (phenylazanediyl) bis 2-triyl)) tetrakis (azanediyl)) tetraphenol (yield 90%).
합성예 11-3. 화합물 110의 제조Synthesis Example 11-3. Preparation of Compound 110
500ml 반응기에 THF 200mL, 3,3',3'',3'''-((6,6'-(phenylazanediyl)bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 26.9 g (39.5 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 methacryloyl chloride 16.5g(158.13mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 110] 30.9 g (수율 82%)을 제조하였다.To a 500 ml reactor were added 200 ml of THF, 3,3 ', 3'',3''' - ((6,6 '- (phenylazanediyl) bis (1,3,5-triazine-6,4,2- (azanediyl)) tetraphenol (26.9 g, 39.5 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 16.5 g (158.13 mmol) of methacryloyl chloride was slowly added to the above reaction vessel for 30 minutes and then stirred at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure, and then subjected to column purification with ethyl acetate: hexane = 1: 3 to obtain 30.9 g (yield: 82%) of [Compound 110].
합성예 12: 화합물 122의 제조 Synthesis Example 12: Preparation of Compound 122
Figure PCTKR2018010549-appb-I000085
Figure PCTKR2018010549-appb-I000085
합성예 12-1. N1,N3-bis(4,6-dichloro-1,3,5-triazin-2-yl)benzene-1,3-diamine의 제조Synthesis Example 12-1. Preparation of N1, N3-bis (4,6-dichloro-1,3,5-triazin-2-yl) benzene-1,3-diamine
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 20.0 g(108.5 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 benzene-1,3-diamine 5.9 g(54.2 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 17.8 g(216.9 mmol)을 가한다. 상온에서 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 N1,N3-bis(4,6-dichloro-1,3,5-triazin-2-yl)benzene-1,3-diamine 15.5g (수율 71%)을 제조하였다.200 mL of THF is added to a 500 mL reactor, and 20.0 g (108.5 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.9 g (54.2 mmol) of benzene-1,3-diamine is added slowly with stirring for 30 minutes and then 17.8 g (216.9 mmol) of sodium acetate are added. Stir at room temperature for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain 15.5 g (yield: 71%) of white solid N1 and N3-bis (4,6-dichloro-1,3,5-triazin- .
합성예 12-2. Synthesis Example 12-2.
4,4',4'',4'''-((6,6'-(1,3-phenylenebis(azanediyl))bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol의 제조Bis (1,3,5-triazine-6,4,2-triyl)) -, (4,6 ' tetrakis (azanediyl)) tetraphenol
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 N1,N3-bis(4,6-dichloro-1,3,5-triazin-2-yl)benzene-1,3-diamine 15.5 g(38.5 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 4-aminophenol 16.8 g(154.0 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 12.6 g(154.0 mmol)을 가한다. 반응용기를 80℃까지 온도를 올린 후 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 4,4',4'',4'''-((6,6'-(1,3-phenylenebis(azanediyl))bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 23.8g (수율 89%)을 제조하였다.200 mL of THF was charged into a 500 mL reactor and 15.5 g (38.5 mmol) of N1, N3-bis (4,6-dichloro-1,3,5-triazin- . After cooling the reaction flask to 0 ° C, 16.8 g (154.0 mmol) of 4-aminophenol was slowly added for 30 minutes while stirring, and 12.6 g (154.0 mmol) of sodium acetate was added thereto. The reaction vessel is heated to 80 < 0 > C and stirred for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain white solid 4,4 ', 4'',4''' - ((6,6 '- (1,3-phenylenebis (azanediyl) -triazine-6,4,2-triyl)) tetrakis (azanediyl)) tetraphenol (yield 89%).
합성예 12-3. 화합물 122의 제조Synthesis Example 12-3. Preparation of Compound 122
500ml 반응기에 THF 200mL, 4,4',4'',4'''-((6,6'-(1,3-phenylenebis(azanediyl))bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 23.8 g (34.3 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 acryloyl chloride 12.4g(137.0 mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 122] 26.5 g (수율 85%)을 제조하였다.To a 500 ml reactor were added 200 ml of THF, 4,4 ', 4'', 4 "' - ((6,6 '- (1,3-phenylenebis (azanediyl) , 2-triyl)) tetrakis (azanediyl)) tetraphenol (23.8 g, 34.3 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. Add 12.4 g (137.0 mmol) of acryloyl chloride to the above reaction vessel slowly for 30 minutes and then stir at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure, and then subjected to column purification with ethyl acetate: hexane = 1: 3 to obtain 26.5 g (yield: 85%) of [Compound 122].
합성예 13: 화합물 123의 제조 Synthesis Example 13: Preparation of Compound 123
Figure PCTKR2018010549-appb-I000086
Figure PCTKR2018010549-appb-I000086
합성예 13-1. N1,N3-bis(4,6-dichloro-1,3,5-triazin-2-yl)benzene-1,3-diamine의 제조Synthesis Example 13-1. Preparation of N1, N3-bis (4,6-dichloro-1,3,5-triazin-2-yl) benzene-1,3-diamine
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 2,4,6-trichloro-1,3,5-triazine 20.0 g(108.5 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 benzene-1,3-diamine 5.9 g(54.2 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 17.8 g(216.9 mmol)을 가한다. 상온에서 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 N1,N3-bis(4,6-dichloro-1,3,5-triazin-2-yl)benzene-1,3-diamine 16.4g (수율 75%)을 제조하였다.200 mL of THF is added to a 500 mL reactor, and 20.0 g (108.5 mmol) of 2,4,6-trichloro-1,3,5-triazine is added under a nitrogen atmosphere. After cooling the reaction flask to 0 ° C, 5.9 g (54.2 mmol) of benzene-1,3-diamine is added slowly with stirring for 30 minutes and then 17.8 g (216.9 mmol) of sodium acetate are added. Stir at room temperature for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain 16.4 g (yield 75%) of white solid N1 and N3-bis (4,6-dichloro-1,3,5-triazin- .
합성예 13-2. Synthesis Example 13-2.
3,3',3'',3'''-((6,6'-(1,3-phenylenebis(azanediyl))bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol의 제조3,3 ', 3' ', 3' '- ((6,6' - (1,3-phenylenebis (azanediyl) bis (1,3,5-triazine-6,4,2- tetrakis (azanediyl)) tetraphenol
500 mL 반응기에 THF 200 ml를 넣고 질소분위기 하에 N1,N3-bis(4,6-dichloro-1,3,5-triazin-2-yl)benzene-1,3-diamine 16.4 g(40.7 mmol)을 가한다. 반응플라스크를 0oC로 냉각한 뒤 3-aminophenol 17.8 g(162.7.0 mmol)을 교반하면서 30분 동안 천천히 가한 후 sodium acetate 13.3 g(162.7.0 mmol)을 가한다. 반응용기를 80℃까지 온도를 올린 후 10시간 동안 교반한다. 반응종료 후 증류수 150ml를 첨가하고 교반하여 흰색 고체 3,3',3'',3'''-((6,6'-(1,3-phenylenebis(azanediyl))bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 25.4g (수율 90%)을 제조하였다.200 mL of THF was charged into a 500 mL reactor and 16.4 g (40.7 mmol) of N1, N3-bis (4,6-dichloro-1,3,5-triazin- . After cooling the reaction flask to 0 ° C, 17.8 g (162.7.0 mmol) of 3-aminophenol was slowly added over 30 minutes while stirring, and 13.3 g (162.7.0 mmol) of sodium acetate was added thereto. The reaction vessel is heated to 80 < 0 > C and stirred for 10 hours. After completion of the reaction, 150 ml of distilled water was added and stirred to obtain white solid 3,3 ', 3'',3''-((6,6' - (1,3-phenylenebis (azanediyl) -triazine-6,4,2-triyl)) tetrakis (azanediyl)) tetraphenol (yield 90%).
합성예 13-3. 화합물 123의 제조Synthesis Example 13-3. Preparation of Compound 123
500ml 반응기에 THF 200mL, 3,3',3'',3'''-((6,6'-(1,3-phenylenebis(azanediyl))bis(1,3,5-triazine-6,4,2-triyl))tetrakis(azanediyl))tetraphenol 25.4 g (36.6 mmol)을 순차적으로 가한 후 질소하에서 0oC로 냉각한다. 위 반응용기에 methacryloyl chloride 15.3g(146.4 mmol)을 30분 동안 천천히 가한 후 상온에서 5시간동안 교반한다. 반응종료 후 증류수와 에틸아세테이트로 추출한후 유기층을 MgSO4를 사용하여 건조한다. 감압 농축한 후 에틸아세테이트 : 헥산 = 1: 3으로 컬럼 정제하여 [화합물 123] 30.1 g (수율 85%)을 제조하였다.To a 500 ml reactor were added 200 ml of THF, 3,3 ', 3'',3''-((6,6' - (1,3,6-phenylenebis (azanediyl) , 2-triyl)) tetrakis (azanediyl) tetraphenol (25.4 g, 36.6 mmol) were successively added thereto, followed by cooling to 0 ° C under nitrogen. 15.3 g (146.4 mmol) of methacryloyl chloride is slowly added to the above reaction vessel for 30 minutes, followed by stirring at room temperature for 5 hours. After completion of the reaction, the reaction mixture was extracted with distilled water and ethyl acetate, and the organic layer was dried using MgSO 4 . The mixture was concentrated under reduced pressure, and then subjected to column purification with ethyl acetate: hexane = 1: 3 to obtain 30.1 g (yield: 85%) of [Compound 123].
실시예 1 내지 16 Examples 1 to 16
하기 표 2의 조성에 따라, (A) 비닐페닐옥시 모노머, (B) 광중합성 모노머, (C) 광개시제 D) 이형제, E) UV안정제를 하기 표 2에 기재된 조성비로 갈색 반응기에 넣고 10 시간 동안 교반하여 감광성 조성물을 제조하였다.(B) a photopolymerizable monomer, (C) a photoinitiator D) a release agent, and (E) a UV stabilizer in a composition ratio shown in Table 2, Followed by stirring to prepare a photosensitive composition.
실시예 1 내지 16 및 비교예 1 내지 2에서 사용한 첨가제의 종류는 하기에 기재된 바와 같다.The types of additives used in Examples 1 to 16 and Comparative Examples 1 to 2 are as described below.
(A) 아크릴기 포함 모노머(A) an acrylic group-containing monomer
화합물2 (M2): ((6-((3-히드록시페닐)아미노)-1,3,5-트리아진-2,4-디일)비스(아잔디일))비스(3,1-피닐렌)디아크릴레이트Compound 2 (M2): ((6 - ((3-hydroxyphenyl) amino) -1,3,5-triazine-2,4-diyl) bis Nylene) diacrylate
화합물4 (M4): ((1,3,5-트리아진-2,4,6-트리일)트리스(아잔디일))트리스(벤젠-4,1-디일)트리아크릴레이트Compound 4 (M4): ((1,3,5-triazine-2,4,6-triyl) tris (acafil)) tris (benzene-4,1-diyl) triacrylate
화합물12 (M12): 4-((4,6-비스((4-히드록시페닐)(메틸)아미노)-1,3,5-트리아진-2-일)(메틸)아미노)페닐아크릴레이트Compound 12 (M12): 4 - ((4,6-bis ((4-hydroxyphenyl) (methyl) amino) -1,3,5-triazin-
화합물25 (M25): ((((1,3,5-트리아진-2,4,6-트리일)트리스(아잔디일))트리스(벤젠-3,1-디일))트리스(옥시))트리스(에탄-2,1-디일)트리아크릴레이트Compound 25 (M25): ((((1,3,5-triazine-2,4,6-triyl) tris (azaneil)) tris (benzene- ) Tris (ethane-2,1-diyl) triacrylate
화합물40 (M40): ((6-((4-메톡시페닐)아미노)-1,3,5-트리아진-2,4-디일)비스(아잔디일))비스(3,1-페닐렌)비스(2-메틸아크릴레이트)Compound 40 (M40): ((6 - ((4-methoxyphenyl) amino) -1,3,5-triazine-2,4- Bis (2-methyl acrylate)
화합물81 (M81): ((6-((2-(아크릴로일옥시)에틸)아미노)-1,3,5-트리아진-2,4-디일)비스(설판디일))비스(에탄-2,1-디일)디아크릴레이트Compound 81 (M81): ((6- ((2- (acryloyloxy) ethyl) amino) -1,3,5-triazine-2,4-diyl) bis (sulfanediyl) 2,1-diyl) diacrylate
화합물83 (M83): ((6-((2-(아크릴로일옥시)에틸)아미노)-1,3,5-트리아진-2,4-디일)비스(옥시))비스(에탄-2,1-디일)디아크릴레이트 Compound 83 (M83): ((6- ((2- (acryloyloxy) ethyl) amino) -1,3,5-triazine-2,4-diyl) bis (oxy) , 1-diyl) diacrylate
화합물85 (M85): ((6-((2-(메타아크릴옥시)에틸)티오)-1,3,5-트리아진-2,4-디일)비스(메틸아잔디일))비스(에탄-2,1-디일)비스(2-메틸아크릴레이트)Compound 85 (M85): ((6 - ((2- (methacryloxy) ethyl) thio) -1,3,5-triazine-2,4- -2,1-diyl) bis (2-methyl acrylate)
화합물99 (M99): ((((6-((2-(아크릴옥시)에틸)아미노)-1,3,5-트리아진-2,4-디일)비스(설판디일))비스(3,1-페닐렌))비스(옥시))비스(에탄-2,1-디일) 디아크릴레이트Compound 99 (M99): ((((6- ((2- (acryloxy) ethyl) amino) -1,3,5-triazine-2,4-diyl) bis (sulfanediyl) 1-phenylene)) bis (oxy)) bis (ethane-2,1-diyl) diacrylate
화합물109 (M109): ((6,6'-(페닐아잔디일)비스(1,3,5-트리아진-6,4,2- 트리일))테트라키스(아잔디일))테트라키스(벤젠-4,1-디일)테트라아크릴레이트Compound 109 (M109): ((6,6 '- (Phenyllaurel) bis (1,3,5-triazine-6,4,2-triyl)) tetrakis (Benzene-4,1-diyl) tetraacrylate
화합물110 (M110): ((6,6'-(페닐아잔디일)비스(1,3,5-트리아진-6,4,2- 트리일))테트라키스(아잔디일))테트라키스(벤젠-3,1-디일)테트라키스(2-메틸아크릴레이트)Compound 110 (M110): ((6,6 '- (Phenyllaurel) bis (1,3,5-triazine-6,4,2-triyl)) tetrakis (Benzene-3,1-diyl) tetrakis (2-methylacrylate)
화합물122 (M122): ((6,6'-(1,3-페닐렌비스(아잔디일))비스(1,3,5-트리아진 -6,4,2-트리일))테트라키스(아잔디일))테트라키스(벤젠-4,1-디일)테트라아크릴레이트Compound 122 (M122): ((6,6 '- (1,3-phenylenebis (acryle)) bis (1,3,5-triazine-6,4,2-triyl)) tetrakis (Aramyl)) tetrakis (benzene-4,1-diyl) tetraacrylate
화합물123 (M123): ((6,6'-(1,3-페닐렌비스(아잔디일))비스(1,3,5-트리아진 -6,4,2-트리일))테트라키스(아잔디일))테트라키스(벤젠-3,1-디일)테트라키스(2-메틸아크릴레이트)Synthesis of Compound 123 (M123): ((6,6 '- (1,3-phenylenebis (aspartyl)) bis (1,3,5-triazine-6,4,2-triyl) (Arampai)) tetrakis (benzene-3,1-diyl) tetrakis (2-methylacrylate)
(B) 광중합성 화합물: (B) Photopolymerizable compound:
B1 : 2-([1,1'-비페닐]-2-일옥시)에틸아크릴레이트B1: 2 - ([1,1'-biphenyl] -2-yloxy) ethyl acrylate
B2 : 디펜타에리스리톨펜타아크릴레이트      B2: dipentaerythritol pentaacrylate
(C) 광중합 개시제:(C) Photopolymerization initiator:
C1 : 디페닐-2,4,6-트리메틸벤조일포스핀옥사이드C1: Diphenyl-2,4,6-trimethylbenzoylphosphine oxide
C2 : (1-히드록시시클로헥실)(페닐)메타논C2: (1-hydroxycyclohexyl) (phenyl) methanone
(D) 이형제        (D) Releasing agent
D1 : 실리콘계 이형제       D1: Silicone-based release agent
(E) UV안정제       (E) UV stabilizer
E1 : 아민계 UV 안정제       E1: Amine-based UV stabilizer
비교예 1 내지 비교예 2Comparative Examples 1 to 2
실시예 1과 실시예 2에서 고굴절모노머를 화합물 2 또는 화합물 4 대신에 하기 R1 (((9H-플루오렌-9,9-디일)비스(4,1-페닐렌))비스(옥시))비스(에탄-2,1-디인) 디아크릴레이트를 사용한 것을 제외하고는 동일한 방법으로 제조하였다.In Example 1 and Example 2, the high-refraction monomers were prepared by using the following R1 (((9H-fluorene-9,9-diyl) bis (4,1- phenylene)) bis (Ethane-2, 1 -dine) diacrylate.
Figure PCTKR2018010549-appb-I000087
Figure PCTKR2018010549-appb-I000087
R1) R1)
[표 2][Table 2]
Figure PCTKR2018010549-appb-I000088
Figure PCTKR2018010549-appb-I000088
실험예 1: 굴절율 평가Experimental Example 1: Evaluation of refractive index
합성된 고굴절 아크릴모노머를 2-([1,1'-비페닐]-2-일옥시)에틸아크릴레이트에 동일량의 무게비로 녹인 후 25oC에서 ABBE 굴절계로 측정하였다. The synthesized high-refractive-index acrylic monomer was dissolved in the same weight ratio to 2 - ([1,1'-biphenyl] -2-yloxy) ethyl acrylate and then measured by ABBE refractometer at 25 ° C.
실험예 2: 점도 평가Experimental Example 2: Evaluation of viscosity
합성된 고굴절 아크릴모노머를 2-([1,1'-비페닐]-2-일옥시)에틸아크릴레이트에 동일량의 무게비로 녹인 후 25oC에서 브룩필드 점도계로 점도를 측정하였다. The high-refractive-index acrylic monomers thus synthesized were dissolved in the same weight ratio to 2 - ([1,1'-biphenyl] -2-yloxy) ethyl acrylate, and the viscosity was measured with a Brookfield viscometer at 25 ° C.
실험예 3: 투과도 평가Experimental Example 3: Evaluation of permeability
광학용 PET 기판 위에 500 mJ/cm2으로 UV 조사하여 가교된 프리즘 시트 시편을 제조하였다. 가교된 프리즘 시트를 UV-vis을 사용하여 400 nm에서 UV 투과도를 측정하였다. A crosslinked prism sheet specimen was prepared by UV irradiation at 500 mJ / cm 2 on an optical PET substrate. The crosslinked prism sheet was measured for UV transmittance at 400 nm using a UV-vis.
실험예 4: 항변지수(△YI) 평가EXPERIMENTAL EXAMPLE 4: Evaluation of the Probe Index (DELTA YI)
가교된 프리즘 시트를 신뢰성 평가 설비 (QUV tester)를 사용하여 60oC에서 UVA lamp 1J 8시간 습도 95% 조건으로 8시간을 반복하여 120시간 동안 진행한 후 초기 Yellow Index값 대비 변화수치인 △YI 값을 측정하였다.The crosslinked prism sheet was subjected to a UVA lamp 1J for 8 hours at 95 ° C for 8 hours at 60 ° C using a reliability evaluation system (QUV tester) for 120 hours and then the value of change ΔYI Respectively.
평가 결과는 하기 표 3에 기재하였다.The evaluation results are shown in Table 3 below.
[표 3][Table 3]
Figure PCTKR2018010549-appb-I000089
Figure PCTKR2018010549-appb-I000089
상기 표 3에 나타난 바와 같이, 본 발명의 실시예 1 내지 16의 감광성 조성물은 비교예 1 내지 2의 조성물에 비해 현저히 높은 굴절율을 나타내었으며 유사한 점도를 나타내었다. 프리즘 시트로 평가한 결과 비교예 1 내지 2의 조성물에 비해 광 투과율이 우수하였으며, 신뢰성 평가 후의 황변 특성이 우수함을 확인하였다. As shown in Table 3, the photosensitive compositions of Examples 1 to 16 of the present invention exhibited remarkably high refractive index and similar viscosities to those of the compositions of Comparative Examples 1 and 2. As a result of evaluating with a prism sheet, the light transmittance was excellent as compared with the compositions of Comparative Examples 1 and 2, and it was confirmed that the yellowing property after the reliability evaluation was excellent.
이상에서 본 발명의 바람직한 실시예들에 대하여 상세하게 설명하였지만 본 발명의 권리 범위는 이에 한정되는 것은 아니고 다음의 청구 범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리 범위에 속하는 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, And falls within the scope of the invention.
본 발명에 따른 트리아진 유도체 화합물은 감광성 조성물에 이용되어 광가교 공정 이후의 굴절율이 높은 특성을 나타내어, 종래 기술에 따른, 황변현상으로 인해 광학시트의 색변화되는 문제를 해결하여 높은 투과도와 내황변 특성이 우수한 감광성 조성물을 제공할 수 있어, 프리즘 시트, 마이크로렌즈, LCD용 코팅 재료, DBEF(Dual Brightness Enhancement Film) 필름, 유기발광소자(OLED)용 코팅 재료, 광학렌즈, 다초점렌즈 등의 제조를 위한 물질로 적용이 가능하여 산업적 응용 가능성이 높다.The triazine derivative compound according to the present invention is used in a photosensitive composition and exhibits a high refractive index after the photo-crosslinking process, and solves the problem of color change of the optical sheet due to yellowing phenomenon according to the prior art, (DBEF) film, a coating material for an organic light emitting device (OLED), an optical lens, a multifocal lens, and the like can be provided. It is possible to apply it as a material for industrial application.

Claims (24)

  1. 하기 [화학식 A] 내지 [화학식 C] 중 어느 하나로 표시되는 화합물.A compound represented by any one of the following formulas (A) to (C).
    [화학식 A](A)
    Figure PCTKR2018010549-appb-I000090
    Figure PCTKR2018010549-appb-I000090
    상기 [화학식 A]에서, In the above formula (A)
    상기 Ra는 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기에서 선택되는 어느 하나의 치환기이고,Ra is any substituent selected from hydrogen, deuterium, substituted or unsubstituted C 1 -C 6 alkyl group,
    상기 L1 은 단일결합, O, S, -N(-R5)- 중에서 선택된 어느 하나이며, Wherein L1 is a single bond, O, S, or -N (-R5) -,
    상기 L2는 단일결합, O, S, -N(-R6)- 중에서 선택된 어느 하나이며, L2 is a single bond, O, S, or -N (-R6) -,
    상기 X1 내지 X3는 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, O, S, -N(-R7)-, -O((CH2)mO)n- 중에서 선택된 어느 하나이되, 상기 m 및 n은 각각 동일하거나 상이하며, 서로 독립적으로 1 내지 4 중에서 선택되는 정수이고, 상기 X1 내지 X3 중 2이상이 각각 -N(-R7)- 를 선택하거나 또는 상기 X1 내지 X3 중 2이상이 각각 -O((CH2)mO)n-를 선택하는 경우에 각각의 -N(-R7)- 및 -O((CH2)mO)n-는 각각 동일하거나 상이하며, X 1 to X 3 are the same or different and independently of each other are a single bond, O, S, -N (-R 7) - or -O ((CH 2 ) m O) n - n is an integer selected from 1 to 4, and at least two of X1 to X3 each represent -N (-R7) -, or two or more of X1 to X3 each independently represent - O ((CH 2) m O ) n - each -N (-R7) in the case of selecting - and -O ((CH 2) m O ) n - may be identical to or different from each other, and
    상기 R4 내지 R7은 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C50의 아릴기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C7-C24의 아릴알킬기 중에서 선택된 어느 하나이고, Wherein R4 to R7 are the same or different, independently represent hydrogen, deuterium, substituted or unsubstituted C 1 -C 30 an alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted C 6 -C 50 ring, each ring of A C 3 -C 30 cycloalkyl group, and a substituted or unsubstituted C 7 -C 24 arylalkyl group,
    상기 W1은 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기 중에서 선택되는 어느 하나이고,Wherein W1 is any one selected from an alkylene group of a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, a substituted or unsubstituted C 1 -C 12 a,
    상기 W2 및 W3는 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, 치환 또는 비치환된 C1-C30의 알킬렌기, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C2-C30의 알케닐렌기, 치환 또는 비치환된 C3-C30의 시클로알킬렌기, 치환 또는 비치환된 C5-C30의 시클로알케닐렌기, 치환 또는 비치환된 C2-C50의 헤테로아릴렌기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬렌기 중에서 선택되는 어느 하나이며,Wherein W2 and W3 are the same or different and each independently represent a single bond, a substituted or unsubstituted C 1 a C 6 aryl group, a substituted or unsubstituted ring of -C 30 alkylene group, a substituted or unsubstituted -C 30 unsubstituted C 2 -C 30 of alkenylene group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group, the substituted or unsubstituted C 2 -C 50 hetero arylene group, and any one is selected from a substituted or unsubstituted heterocycloalkyl group of C 2 -C 30 a,
    상기 Y1 및 Y2는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C2-C30의 알케닐기, 치환 또는 비치환된 C2-C20의 알키닐기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C5-C30의 시클로알케닐기, 치환 또는 비치환된 C2-C50의 헤테로아릴기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬기, 치환 또는 비치환된 C1-C30의 알킬실릴기, 치환 또는 비치환된 C6-C30의 아릴실릴기 및, 하기 [구조식 1] 또는 [구조식 2]로 표시되는 치환기 중에서 선택된 어느 하나이며,Wherein Y1 and Y2 are the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or non-substituted of unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 of each ring C, respectively of 2 -C 30 alkenyl group, a substituted or unsubstituted C 2 -C 20 alkynyl of the group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group , A substituted or unsubstituted C 2 -C 50 heteroaryl group, a substituted or unsubstituted C 2 -C 30 heterocycloalkyl group, a substituted or unsubstituted C 1 -C 30 alkylsilyl group, a substituted or unsubstituted A C 6 -C 30 arylsilyl group, and a substituent group represented by the following structural formula 1 or 2:
    [구조식 1] [구조식 2][Structural formula 1] [Structural formula 2]
    Figure PCTKR2018010549-appb-I000091
    Figure PCTKR2018010549-appb-I000091
    상기 [구조식 1]과 [구조식 2]에서, In the above Structural Formula 1 and Structural Formula 2,
    상기 Rb 및 Rc 는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기 중에서 선택된 어느 하나이며, Wherein Rb and Rc are each the same or different, and independently are any one selected from the group consisting of hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6 with each other,
    상기 구조식 1 및 구조식2 내 “-*”는 각각 상기 화학식 A내 X2 또는 X3와 결합되는 결합 사이트를 의미하고,"- *" in the structural formulas 1 and 2 means a bonding site in which X2 or X3 in the above formula (A) is bonded,
    [화학식 B][Chemical Formula B]
    Figure PCTKR2018010549-appb-I000092
    Figure PCTKR2018010549-appb-I000092
    [화학식 C]≪ RTI ID = 0.0 &
    Figure PCTKR2018010549-appb-I000093
    Figure PCTKR2018010549-appb-I000093
    상기 [화학식 B]에서, In the above formula (B)
    상기 Ar1은 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C2-C30의 헤테로아릴렌기, 치환 또는 비치환된 C1-C30의 알킬렌기, 치환 또는 비치환된 C2-C30의 알케닐렌기, 치환 또는 비치환된 C3-C30의 시클로알킬렌기, 치환 또는 비치환된 C5-C30의 시클로알케닐렌기 중에서 선택되는 어느 하나이고,Wherein Ar 1 is a substituted or unsubstituted C 6 -C 30 arylene group, a substituted or unsubstituted C 2 -C 30 heteroarylene group, a substituted or unsubstituted C 1 -C 30 alkylene group, and the one which is C 2 -C 30 alkenylene group, selected from substituted or unsubstituted C 3 -C 30 cycloalkylene group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group of the,
    L6은 단일결합, O, S, -N(-R11)- 중에서 선택된 어느 하나이고,L6 is any one selected from a single bond, O, S, -N (-R11) -,
    L7은 단일결합, O, S, -N(-R12)- 중에서 선택된 어느 하나이며,L7 is any of a single bond, O, S, -N (-R12) -,
    상기 [화학식 C]에서, In the above formula (C)
    상기 Ar2는 수소, 중수소, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C2-C30의 헤테로아릴기, 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C2-C30의 알케닐기, 치환 또는 비치환된 C5-C30의 시클로알케닐기 중에서 선택되는 어느 하나이고,Substituted or unsubstituted C 6 -C 30 aryl group, substituted or unsubstituted C 2 -C 30 heteroaryl group, substituted or unsubstituted C 1 -C 30 alkyl group, substituted Or an unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 2 -C 30 alkenyl group, or a substituted or unsubstituted C 5 -C 30 cycloalkenyl group,
    상기 [화학식 B] 내지 [화학식 C]에서, In the above formulas (B) to (C)
    상기 Rd는 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기에서 선택되는 어느 하나의 치환기이고,Wherein Rd is a substituent of any one selected from hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6,
    상기 L3 내지 L5는 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, O, S, -N(-R9)- 중에서 선택된 어느 하나이며,Each of L3 to L5 is the same or different and independently selected from a single bond, O, S, or -N (-R9) -,
    상기 L3 내지 L5 중 2이상이 각각 -N(-R9)- 를 선택하는 경우에 각각의 -N(-R9)는 동일하거나 상이하며,When two or more of L3 to L5 each represent -N (-R9) -, each of -N (-R9) is the same or different,
    상기 X4 내지 X7은 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, O, S, -N(-R10)-, -O((CH2)mO)n- 중에서 선택된 어느 하나이되, 상기 m 및 n은 각각 동일하거나 상이하며, 서로 독립적으로 1 내지 4 중에서 선택되는 정수이고,Wherein X4 to X7 are the same or different and each, independently of one another a single bond, O, S, -N (-R10 ) -, -O ((CH 2) m O) n - are optionally replaced with one selected from said m and n are the same or different and are each independently an integer selected from 1 to 4,
    상기 X4 내지 X7 중 2이상이 각각 -N(-R10)-를 선택하거나, 또는 상기 X4 내지 X7 중 2이상이 각각 -O((CH2)mO)n-를 선택하는 경우에 각각의 -N(-R10)- 및 -O((CH2)mO)n-는 동일하거나 상이하며,The at least two of the X4 to X7 -N (-R10) respectively select, or at least two of the X4 to X7 is n -O ((CH 2) m O) , respectively - if the select on each - N (-R 10) - and -O ((CH 2 ) m O) n - are the same or different,
    상기 R8 내지 R12는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C7-C24의 아릴알킬기 중에서 선택된 어느 하나이고, Wherein R8 to R12 are the same or different, independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or unsubstituted of C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 ring, each ring of the A C 3 -C 30 cycloalkyl group, and a substituted or unsubstituted C 7 -C 24 arylalkyl group,
    상기 W4는 단일결합, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C1-C12의 알킬렌기 중에서 선택되는 어느 하나이고,W4 is any one selected from the group consisting of a single bond, a substituted or unsubstituted C 6 -C 30 arylene group, and a substituted or unsubstituted C 1 -C 12 alkylene group,
    상기 W5 내지 W7은 각각 동일하거나 상이하며, 서로 독립적으로 단일결합, 치환 또는 비치환된 C1-C30의 알킬렌기, 치환 또는 비치환된 C6-C30의 아릴렌기, 치환 또는 비치환된 C2-C30의 알케닐렌기, 치환 또는 비치환된 C3-C30의 시클로알킬렌기, 치환 또는 비치환된 C5-C30의 시클로알케닐렌기, 치환 또는 비치환된 C2-C50의 헤테로아릴렌기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬렌기 중에서 선택되는 어느 하나이며,The W5 to W7 are the same or different and each independently represent a single bond, a substituted or unsubstituted C 1 -C 30 an alkyl group, an arylene group, a substituted or unsubstituted substituted or unsubstituted C 6 -C 30 unsubstituted C 2 -C 30 of alkenylene group, a substituted or unsubstituted C 3 -C 30 cycloalkyl group, a substituted or unsubstituted C 5 -C 30 cycloalkenyl group, the substituted or unsubstituted C 2 -C 50 hetero arylene group, and any one is selected from a substituted or unsubstituted heterocycloalkyl group of C 2 -C 30 a,
    상기 Y3 내지 Y5는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 치환 또는 비치환된 C1-C30의 알킬기, 치환 또는 비치환된 C6-C30의 아릴기, 치환 또는 비치환된 C3-C30의 시클로알킬기, 치환 또는 비치환된 C2-C50의 헤테로아릴기, 치환 또는 비치환된 C2-C30의 헤테로시클로알킬기, 치환 또는 비치환된 C1-C30의 알킬실릴기, 치환 또는 비치환된 C6-C30의 아릴실릴기 및, 하기 [구조식 1] 또는 [구조식 2]로 표시되는 치환기 중에서 선택된 어느 하나이며,The Y3 to Y5 are the same or different, and independently represent hydrogen, deuterium, substituted or unsubstituted aryl group, a substituted or non-substituted of unsubstituted C 1 -C 30 alkyl group, a substituted or unsubstituted C 6 -C 30 of each ring C, respectively 3 to 30 carbon atoms, a substituted or unsubstituted C 2 to C 50 heteroaryl group, a substituted or unsubstituted C 2 to C 30 heterocycloalkyl group, a substituted or unsubstituted C 1 to C 30 alkyl A silyl group, a substituted or unsubstituted C 6 -C 30 arylsilyl group, and a substituent group represented by the following Structural Formula 1 or Structural Formula 2,
    [구조식 1] [구조식 2][Structural formula 1] [Structural formula 2]
    Figure PCTKR2018010549-appb-I000094
    Figure PCTKR2018010549-appb-I000094
    상기 [구조식 1]과 [구조식 2]에서, In the above Structural Formula 1 and Structural Formula 2,
    상기 Rb 및 Rc는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C6의 알킬기 중에서 선택된 어느 하나이며,Wherein Rb and Rc are each the same or different, and independently are any one selected from the group consisting of hydrogen, deuterium, an alkyl group a substituted or unsubstituted C 1 -C 6 with each other,
    상기 구조식 1 및 구조식2 내 “-*”는 각각 상기 [화학식 B] 또는 [화학식 C]내 X5 내지 X7과 결합되는 결합 사이트를 의미하고,"- *" in the structural formulas 1 and 2 means a binding site in which X5 to X7 in the above-mentioned formula (B) or (C) are bonded,
    상기 [화학식 A] 내지 [화학식 C]에서의 ‘치환 또는 비치환된’에서의 ‘치환’은 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, C1-C24의 알킬기, C1-C24의 할로겐화된 알킬기, C2-C24의 알케닐기, C2-C24의 알키닐기, C1-24의 헤테로알킬기, C6-C24의 아릴기, C7-C24의 아릴알킬기, C2-C24의 헤테로아릴기, C2-C24의 헤테로아릴알킬기, C1-C24의 알콕시기, C1-C24의 알킬티오닐기, C1-C24의 알킬아미노기, C6-C24의 아릴아미노기, C1-C24의 헤테로 아릴아미노기, C1-C24의 알킬실릴기, C6-C24의 아릴실릴기, C6-C24의 아릴옥시기, C6-C24의 아릴티오닐기로 이루어진 군에서 선택된 1개 이상의 치환기로 치환되는 것을 의미한다.Wherein Formula A] to [Chemical Formula C] "substituted" in the "substituted or unsubstituted" in the heavy hydrogen, a cyano group, a halogen group, a hydroxyl group, a nitro group, an alkyl group of C 1 -C 24, C 1 -C A C 2 -C 24 alkenyl group, a C 2 -C 24 alkynyl group, a C 1 - 24 heteroalkyl group, a C 6 -C 24 aryl group, a C 7 -C 24 arylalkyl group, A C 2 -C 24 heteroaryl group, a C 2 -C 24 heteroarylalkyl group, a C 1 -C 24 alkoxy group, a C 1 -C 24 alkylthioyl group, a C 1 -C 24 alkylamino group, a C C 6 -C 24 arylamino groups, C 1 -C 24 heteroarylamino groups, C 1 -C 24 alkylsilyl groups, C 6 -C 24 arylsilyl groups, C 6 -C 24 aryloxy groups, C 6 And an arylthionyl group of -C 24 .
  2. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 치환기 R4 내지 R6는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C20의 알킬기, 치환 또는 비치환된 C6-C20의 아릴기 중에서 선택되는 어느 하나이고, Wherein Formula A] within the substituent R4 to R6 are each the same or different, and independently represent hydrogen, deuterium, a substituted or unsubstituted C 1 -C 20 alkyl group, a substituted or unsubstituted C 6 -C 20 aryl group , ≪ / RTI >
    Ra, Rb 및 Rc는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소 메틸기 에서 선택되는 어느 하나의 치환기 인 것을 특징으로 하는 화합물.Ra, Rb and Rc are the same or different and independently of each other are any substituent selected from the group consisting of hydrogen and a deuterium methyl group.
  3. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 Y1 및 Y2 중 적어도 하나는 구조식 1 또는 구조식 2인 것을 특징으로 하는 화합물.Wherein at least one of Y1 and Y2 in the above formula (A) is a structural formula (1) or a structural formula (2).
  4. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 L1 은 -N(-R5)- 또는 S 이고, L2 는 -N(-R6)- 또는 S 인 것을 특징으로 하는 화합물. Wherein L 1 in the formula [A] is -N (-R 5) - or S, and L 2 is -N (-R 6) - or S.
  5. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 L1은 -N(-R5)- 이고, L2 는 -N(-R6)- 이며, L 1 in the above formula (A) is -N (-R 5) -, L 2 is -N (-R 6) -,
    상기 R5 및 R6은 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, C1-C10의 알킬기, C6-C20의 아릴기 중에서 선택되는 어느 하나인 것을 특징으로 하는 화합물.Wherein R5 and R6 are compounds, characterized in that one each of which the same or different and independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 in.
  6. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 W1 내지 W3 중 적어도 하나는 치환 또는 비치환된 C6-C30의 아릴렌기인 것을 특징으로 하는 화합물.Wherein Formula A] in W1 to W3 of at least one compound, characterized in that the arylene group of the substituted or unsubstituted C 6 -C 30.
  7. 제6항에 있어서,The method according to claim 6,
    상기 [화학식 A]내 W1 내지 W3 중 두개 이상이 치환 또는 비치환된 C6-C30의 아릴렌기인 것을 특징으로 하는 화합물.Wherein Formula A] in W1 to W3 of the two or more compounds, characterized in that the arylene group of the substituted or unsubstituted C 6 -C 30.
  8. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 W1은 치환 또는 비치환된 페닐렌기이고,W1 in the above formula (A) is a substituted or unsubstituted phenylene group,
    상기 W2 및 W3 는 동일하거나 상이하며, 이들 중 적어도 하나는 치환 또는 비치환된 C6-C30의 아릴렌기인 것을 특징으로 하는 화합물.Wherein W2 and W3 are the same or different, at least one of which is a compound wherein the arylene group of the substituted or unsubstituted C 6 -C 30.
  9. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A]내 W1 내지 W3 는 각각 동일하거나 상이하며, 이들 중 적어도 2개는 치환 또는 비치환된 페닐렌기 인 것을 특징으로 하는 화합물.W1 to W3 in the formula [A] are the same or different, and at least two of them are a substituted or unsubstituted phenylene group.
  10. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 B] 및 [화학식 C]내 상기 치환기 R8 내지 R12는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 치환 또는 비치환된 C1-C20의 알킬기, 치환 또는 비치환된 C6-C20의 아릴기 중에서 선택되는 어느 하나이고, The Formula B] and [Chemical Formula C] in the substituents R8 to R12 are the same or different and each is, independently, it represents a hydrogen, a deuterium, a substituted or unsubstituted C 1 -C 20, substituted or unsubstituted C 6 to each other, respectively and any one selected from among aryl groups -C 20,
    Rb, Rc 및 Rd는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, 메틸기에서 선택되는 어느 하나의 치환기인 것을 특징으로 하는 화합물.Rb, Rc and Rd are the same or different and independently of each other are any one substituent selected from hydrogen, deuterium and methyl.
  11. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 B] 및 [화학식 C]내 Y3 내지 Y5 중 적어도 하나는 [구조식 1] 또는 [구조식 2]인 것을 특징으로 하는 화합물.At least one of Y3 to Y5 in the above formulas (B) and (C) is represented by [Formula 1] or [Formula 2].
  12. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 B]내 L3 내지 L7은 각각 동일하거나 상이하며 서로 독립적으로 단일결합, -N(-R9)- 또는 S인 것을 특징으로 하는 화합물.Wherein L 3 to L 7 are the same or different and independently of one another are a single bond, -N (-R 9) - or S,
  13. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 C]내 L3 내지 L5는 각각 동일하거나 상이하며 서로 독립적으로 단일결합, -N(-R9)- 또는 S인 것을 특징으로 하는 화합물.L3 to L5 in the above formula (C) are the same or different and independently of one another are a single bond, -N (-R9) - or S.
  14. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 B] 및 [화학식 C]내In the above formulas [B] and [C]
    R9, R11 내지 R12는 각각 동일하거나 상이하며, 서로 독립적으로 수소, 중수소, C1-C10의 알킬기, C6-C20의 아릴기 중에서 선택되는 어느 하나인 것을 특징으로 하는 화합물.R9, R11 to R12 are the compounds wherein any one of each of which are identical or different and independently represent hydrogen, deuterium, aryl selected from the group of C 1 -C 10 alkyl, C 6 -C 20 in.
  15. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 적어도 2개 이상이 치환 또는 비치환된 C6-C30의 아릴렌기인 것을 특징으로 하는 화합물.The Formula B] and [Chemical Formula C] within a W4 through W7 at least two or more of these compounds, characterized in that the arylene group of the substituted or unsubstituted C 6 -C 30.
  16. 제15항에 있어서, 16. The method of claim 15,
    상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 적어도 2개 이상이 치환 또는 비치환된 페닐렌기인 것을 특징으로 하는 화합물.Wherein at least two of W4 to W7 in the above formulas (B) and (C) are substituted or unsubstituted phenylene groups.
  17. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 적어도 3개 이상이 치환 또는 비치환된 C6-C30의 아릴렌기인 것을 특징으로 하는 화합물.The Formula B] and [Chemical Formula C] within a W4 through W7 at least more than two of these compounds, characterized in that the arylene group of the substituted or unsubstituted C 6 -C 30.
  18. 제17항에 있어서, 18. The method of claim 17,
    상기 [화학식 B] 및 [화학식 C]내 W4 내지 W7 중 적어도 3개 이상이 치환 또는 비치환된 페닐렌기인 것을 특징으로 하는 화합물.Wherein at least three of W4 to W7 in the above formulas (B) and (C) are substituted or unsubstituted phenylene groups.
  19. 제1항에 있어서,The method according to claim 1,
    상기 [화학식 A] 내지 [화학식 C]로 표시되는 화합물은 하기 화합물1 내지 134 중에서 어느 하나로 표시되는 것을 특징으로 하는 화합물.The compound represented by any one of the above Chemical Formulas A to C is represented by any one of the following compounds 1 to 134.
    Figure PCTKR2018010549-appb-I000095
    Figure PCTKR2018010549-appb-I000095
    [화합물 1] [화합물 2][Compound 1] [Compound 2]
    Figure PCTKR2018010549-appb-I000096
    Figure PCTKR2018010549-appb-I000096
    [화합물 3] [화합물 4][Compound 3] [Compound 4]
    Figure PCTKR2018010549-appb-I000097
    Figure PCTKR2018010549-appb-I000097
    [화합물 5] [화합물 6][Compound 5] [Compound 6]
    Figure PCTKR2018010549-appb-I000098
    Figure PCTKR2018010549-appb-I000098
    [화합물 7] [화합물 8] [Compound 7] [Compound 8]
    Figure PCTKR2018010549-appb-I000099
    Figure PCTKR2018010549-appb-I000099
    [화합물 9] [화합물 10][Compound 9] [Compound 10]
    Figure PCTKR2018010549-appb-I000100
    Figure PCTKR2018010549-appb-I000100
    [화합물 11] [화합물 12][Compound 11] [Compound 12]
    Figure PCTKR2018010549-appb-I000101
    Figure PCTKR2018010549-appb-I000101
    [화합물 13] [화합물 14][Compound 13] [Compound 14]
    Figure PCTKR2018010549-appb-I000102
    Figure PCTKR2018010549-appb-I000102
    [화합물 15] [화합물 16][Compound 15] [Compound 16]
    Figure PCTKR2018010549-appb-I000103
    Figure PCTKR2018010549-appb-I000103
    [화합물 17] [화합물 18][Compound 17] [Compound 18]
    Figure PCTKR2018010549-appb-I000104
    Figure PCTKR2018010549-appb-I000104
    [화합물 19] [화합물 20][Compound 19] [Compound 20]
    Figure PCTKR2018010549-appb-I000105
    Figure PCTKR2018010549-appb-I000105
    [화합물 21] [화합물 22][Compound 21] [Compound 22]
    Figure PCTKR2018010549-appb-I000106
    Figure PCTKR2018010549-appb-I000106
    [화합물 23] [화합물 24] [Compound 23] [Compound 24]
    Figure PCTKR2018010549-appb-I000107
    Figure PCTKR2018010549-appb-I000107
    [화합물 25] [화합물 26][Compound 25] [Compound 26]
    Figure PCTKR2018010549-appb-I000108
    Figure PCTKR2018010549-appb-I000108
    [화합물 27] [화합물 28][Compound 27] [Compound 28]
    Figure PCTKR2018010549-appb-I000109
    Figure PCTKR2018010549-appb-I000109
    [화합물 29] [화합물 30][Compound 29] [Compound 30]
    Figure PCTKR2018010549-appb-I000110
    Figure PCTKR2018010549-appb-I000110
    [화합물 31] [화합물 32][Compound 31] [Compound 32]
    Figure PCTKR2018010549-appb-I000111
    Figure PCTKR2018010549-appb-I000111
    [화합물 33] [화합물 34][Compound 33] [Compound 34]
    Figure PCTKR2018010549-appb-I000112
    Figure PCTKR2018010549-appb-I000112
    [화합물 35] [화합물 36][Compound 35] [Compound 36]
    Figure PCTKR2018010549-appb-I000113
    Figure PCTKR2018010549-appb-I000113
    [화합물 37] [화합물 38][Compound 37] [Compound 38]
    Figure PCTKR2018010549-appb-I000114
    Figure PCTKR2018010549-appb-I000114
    [화합물 39] [화합물 40][Compound 39] [Compound 40]
    Figure PCTKR2018010549-appb-I000115
    Figure PCTKR2018010549-appb-I000115
    [화합물 41] [화합물 42][Compound 41] [Compound 42]
    Figure PCTKR2018010549-appb-I000116
    Figure PCTKR2018010549-appb-I000116
    [화합물 43] [화합물 44][Compound 43] [Compound 44]
    Figure PCTKR2018010549-appb-I000117
    Figure PCTKR2018010549-appb-I000117
    [화합물 45] [화합물 46][Compound 45] [Compound 46]
    Figure PCTKR2018010549-appb-I000118
    Figure PCTKR2018010549-appb-I000118
    [화합물 47] [화합물 48][Compound 47] [Compound 48]
    Figure PCTKR2018010549-appb-I000119
    Figure PCTKR2018010549-appb-I000119
    [화합물 49] [화합물 50][Compound 49] [Compound 50]
    Figure PCTKR2018010549-appb-I000120
    Figure PCTKR2018010549-appb-I000120
    [화합물 51] [화합물 52][Compound 51] [Compound 52]
    Figure PCTKR2018010549-appb-I000121
    Figure PCTKR2018010549-appb-I000121
    [화합물 53] [화합물 54][Compound 53] [Compound 54]
    Figure PCTKR2018010549-appb-I000122
    Figure PCTKR2018010549-appb-I000122
    [화합물 55] [화합물 56][Compound 55] [Compound 56]
    Figure PCTKR2018010549-appb-I000123
    Figure PCTKR2018010549-appb-I000123
    [화합물 57] [화합물 58][Compound 57] [Compound 58]
    Figure PCTKR2018010549-appb-I000124
    Figure PCTKR2018010549-appb-I000124
    [화합물 59] [화합물 60][Compound 59] [Compound 60]
    Figure PCTKR2018010549-appb-I000125
    Figure PCTKR2018010549-appb-I000125
    [화합물 61] [화합물 62][Compound 61] [Compound 62]
    Figure PCTKR2018010549-appb-I000126
    Figure PCTKR2018010549-appb-I000126
    [화합물 63] [화합물 64][Compound 63] [Compound 64]
    Figure PCTKR2018010549-appb-I000127
    Figure PCTKR2018010549-appb-I000127
    [화합물 65] [화합물 66][Compound 65] [Compound 66]
    Figure PCTKR2018010549-appb-I000128
    Figure PCTKR2018010549-appb-I000128
    [화합물 67] [화합물 68][Compound 67] [Compound 68]
    Figure PCTKR2018010549-appb-I000129
    Figure PCTKR2018010549-appb-I000129
    [화합물 69] [화합물 70][Compound 69] [Compound 70]
    Figure PCTKR2018010549-appb-I000130
    Figure PCTKR2018010549-appb-I000130
    [화합물 71] [화합물 72][Compound 71] [Compound 72]
    Figure PCTKR2018010549-appb-I000131
    Figure PCTKR2018010549-appb-I000131
    [화합물 73] [화합물 74][Compound 73] [Compound 74]
    Figure PCTKR2018010549-appb-I000132
    Figure PCTKR2018010549-appb-I000132
    [화합물 75] [화합물 76][Compound 75] [Compound 76]
    Figure PCTKR2018010549-appb-I000133
    Figure PCTKR2018010549-appb-I000133
    [화합물 77] [화합물 78][Compound 77] [Compound 78]
    Figure PCTKR2018010549-appb-I000134
    Figure PCTKR2018010549-appb-I000134
    [화합물 79] [화합물 80][Compound 79] [Compound 80]
    Figure PCTKR2018010549-appb-I000135
    Figure PCTKR2018010549-appb-I000135
    [화합물 81] [화합물 82][Compound 81] [Compound 82]
    Figure PCTKR2018010549-appb-I000136
    Figure PCTKR2018010549-appb-I000136
    [화합물 83] [화합물 84][Compound 83] [Compound 84]
    Figure PCTKR2018010549-appb-I000137
    Figure PCTKR2018010549-appb-I000137
    [화합물 85] [화합물 86][Compound 85] [Compound 86]
    Figure PCTKR2018010549-appb-I000138
    Figure PCTKR2018010549-appb-I000138
    [화합물 87] [화합물 88][Compound 87] [Compound 88]
    Figure PCTKR2018010549-appb-I000139
    Figure PCTKR2018010549-appb-I000139
    [화합물 89] [화합물 90][Compound 89] [Compound 90]
    Figure PCTKR2018010549-appb-I000140
    Figure PCTKR2018010549-appb-I000140
    [화합물 91] [화합물 92][Compound 91] [Compound 92]
    Figure PCTKR2018010549-appb-I000141
    Figure PCTKR2018010549-appb-I000141
    [화합물 93] [화합물 94][Compound 93] [Compound 94]
    Figure PCTKR2018010549-appb-I000142
    Figure PCTKR2018010549-appb-I000142
    [화합물 95] [화합물 96][Compound 95] [Compound 96]
    Figure PCTKR2018010549-appb-I000143
    Figure PCTKR2018010549-appb-I000143
    [화합물 97] [화합물 98][Compound 97] [Compound 98]
    Figure PCTKR2018010549-appb-I000144
    Figure PCTKR2018010549-appb-I000144
    [화합물 99] [화합물 100][Compound 99] [Compound 100]
    Figure PCTKR2018010549-appb-I000145
    Figure PCTKR2018010549-appb-I000145
    [화합물 101] [화합물 102][Compound 101] [Compound 102]
    Figure PCTKR2018010549-appb-I000146
    Figure PCTKR2018010549-appb-I000146
    [화합물 103] [화합물 104][Compound 103] [Compound 104]
    Figure PCTKR2018010549-appb-I000147
    Figure PCTKR2018010549-appb-I000147
    [화합물 105] [화합물 106][Compound 105] [Compound 106]
    Figure PCTKR2018010549-appb-I000148
    Figure PCTKR2018010549-appb-I000148
    [화합물 107] [화합물 108][Compound 107] [Compound 108]
    Figure PCTKR2018010549-appb-I000149
    Figure PCTKR2018010549-appb-I000149
    [화합물 109] [화합물 110][Compound 109] [Compound 110]
    Figure PCTKR2018010549-appb-I000150
    Figure PCTKR2018010549-appb-I000150
    [화합물 111] [화합물 112][Compound 111] [Compound 112]
    Figure PCTKR2018010549-appb-I000151
    Figure PCTKR2018010549-appb-I000151
    [화합물 113] [화합물 114][Compound 113] [Compound 114]
    Figure PCTKR2018010549-appb-I000152
    Figure PCTKR2018010549-appb-I000152
    [화합물 115] [화합물 116][Compound 115] [Compound 116]
    Figure PCTKR2018010549-appb-I000153
    Figure PCTKR2018010549-appb-I000153
    [화합물 117] [화합물 118][Compound 117] [Compound 118]
    Figure PCTKR2018010549-appb-I000154
    Figure PCTKR2018010549-appb-I000154
    [화합물 119] [화합물 120][Compound 119] [Compound 120]
    Figure PCTKR2018010549-appb-I000155
    Figure PCTKR2018010549-appb-I000155
    [화합물 121] [화합물 122][Compound 121] [Compound 122]
    Figure PCTKR2018010549-appb-I000156
    Figure PCTKR2018010549-appb-I000156
    [화합물 123] [화합물 124][Compound 123] [Compound 124]
    Figure PCTKR2018010549-appb-I000157
    Figure PCTKR2018010549-appb-I000157
    [화합물 125] [화합물 126] [Compound 125] [Compound 126]
    Figure PCTKR2018010549-appb-I000158
    Figure PCTKR2018010549-appb-I000158
    [화합물 127] [화합물 128][Compound 127] [Compound 128]
    Figure PCTKR2018010549-appb-I000159
    Figure PCTKR2018010549-appb-I000159
    [화합물 129] [화합물 130][Compound 129] [Compound 130]
    Figure PCTKR2018010549-appb-I000160
    Figure PCTKR2018010549-appb-I000160
    [화합물 131] [화합물 132][Compound 131] [Compound 132]
    Figure PCTKR2018010549-appb-I000161
    Figure PCTKR2018010549-appb-I000161
    [화합물 133] [화합물 134][Compound 133] [Compound 134]
  20. 제1항 내지 제19항 중 어느 한 항에 기재된 화합물을 포함하는 감광성 조성물.A photosensitive composition comprising the compound according to any one of claims 1 to 19.
  21. 제20항에 있어서, 21. The method of claim 20,
    상기 조성물은 광개시제 또는 광중합성 모노머를 추가적으로 포함하는 것을 특징으로 하는 감광성 조성물.Wherein the composition further comprises a photoinitiator or a photopolymerizable monomer.
  22. 제20항의 감광성 조성물을 중합하여 얻어지는 광학 소재.An optical material obtained by polymerizing the photosensitive composition of claim 20.
  23. 감광성 조성물 100 중량부에 대해서, 제1항 내지 제19항 중 어느 한 항에 기재된 화합물 1 내지 95 중량부, 광중합성 화합물 0 내지 90 중량부 및 광개시제 0.1 내지 20 중량부를 함유하는 것을 특징으로 하는 감광성 조성물.1 to 95 parts by weight of the compound according to any one of claims 1 to 19, 0 to 90 parts by weight of a photopolymerizable compound and 0.1 to 20 parts by weight of a photoinitiator per 100 parts by weight of the photosensitive composition. Composition.
  24. 제23항에 있어서,24. The method of claim 23,
    상기 감광성 조성물은 프리즘시트, 마이크로렌즈, DBEF 필름, LCD용 코팅 재료, 유기발광소자(OLED)용 코팅 재료, 광학렌즈, 다초점렌즈 중에서 선택되는 어느 하나를 제조하기 위해 사용되는 것을 특징으로 하는 감광성 조성물.Wherein the photosensitive composition is used for producing any one selected from a prism sheet, a microlens, a DBEF film, a coating material for an LCD, a coating material for an OLED, an optical lens and a multifocal lens. Composition.
PCT/KR2018/010549 2017-09-13 2018-09-10 Novel triazine derivative and photosensitive composition comprising same WO2019054707A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201880057939.8A CN111065628B (en) 2017-09-13 2018-09-10 Novel triazine derivative and photosensitive composition comprising the same
JP2020535948A JP6965455B2 (en) 2017-09-13 2018-09-10 A novel triazine derivative and a photosensitive composition containing the same.
US16/643,250 US11427551B2 (en) 2017-09-13 2018-09-10 Triazine derivative and photosensitive composition comprising same

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20170117396 2017-09-13
KR10-2017-0117396 2017-09-13
KR1020180107042A KR102145580B1 (en) 2017-09-13 2018-09-07 Novel triazine derivatives and photosensitive composition including the same
KR10-2018-0107042 2018-09-07

Publications (1)

Publication Number Publication Date
WO2019054707A1 true WO2019054707A1 (en) 2019-03-21

Family

ID=65723392

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/010549 WO2019054707A1 (en) 2017-09-13 2018-09-10 Novel triazine derivative and photosensitive composition comprising same

Country Status (1)

Country Link
WO (1) WO2019054707A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021230002A1 (en) * 2020-05-15 2021-11-18 富士フイルム株式会社 Curable composition, thermally conductive material, thermally conductive sheet, device with thermally conductive layer, and compound

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03256048A (en) * 1990-03-07 1991-11-14 Nippon Soda Co Ltd Plating resist peeling preventive agent
US5597485A (en) * 1988-05-13 1997-01-28 Vilmax S.A. Process for separating proteins
KR101569344B1 (en) * 2014-05-19 2015-11-16 한국화학연구원 Photo-curable coating composition

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5597485A (en) * 1988-05-13 1997-01-28 Vilmax S.A. Process for separating proteins
JPH03256048A (en) * 1990-03-07 1991-11-14 Nippon Soda Co Ltd Plating resist peeling preventive agent
KR101569344B1 (en) * 2014-05-19 2015-11-16 한국화학연구원 Photo-curable coating composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BU, J. ET AL.: "Preparation and Expansion Properties of a Novel UV-curable Intumescent Flame-retardant Coating", JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, vol. 122, 2015, pages 329 - 338, XP035547092, DOI: doi:10.1007/s10973-015-4733-7 *
GRABCHEV, I. ET AL.: "Photoisomerization of Triazine-stilbene Fluorescent Brighteners in Solution and in Their Copolymers with Styrene", ZEITSCHRIFT FUR NATURFORSCHUNG, vol. 55, 2000, pages 833 - 836, XP055584993 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021230002A1 (en) * 2020-05-15 2021-11-18 富士フイルム株式会社 Curable composition, thermally conductive material, thermally conductive sheet, device with thermally conductive layer, and compound
JPWO2021230002A1 (en) * 2020-05-15 2021-11-18
JP7440626B2 (en) 2020-05-15 2024-02-28 富士フイルム株式会社 Curable compositions, thermally conductive materials, thermally conductive sheets, devices with thermally conductive layers, compounds

Similar Documents

Publication Publication Date Title
WO2016122117A1 (en) Metal complex and color conversion film comprising same
WO2015108386A1 (en) Novel β-oximester fluorene compound, a photopolymerization initiator comprising same, and photoresist composition
WO2017155297A2 (en) Compound and color conversion film comprising same
WO2018044120A1 (en) Compound and color conversion film comprising same
WO2016129861A1 (en) Novel compound for organic electric element, organic electric element using same, and electronic device comprising same
WO2016126070A1 (en) Novel oximester derivative compound, and photopolymerization initiator and photoresist composition containing same
WO2016129867A1 (en) Novel compound for organic electric element, organic electric element using same, and electronic device comprising same
WO2013069939A1 (en) Compound for organic electronic element, organic electronic element including the same, electronic device thereof
WO2021010700A1 (en) Compound, photosensitive fluorescent resin composition comprising same, color conversion film, backlight unit, and display device
WO2021045466A1 (en) Compound, core-shell dye, photosensitive resin composition including same, and color filter
WO2021177748A1 (en) Compound and optical film comprising same
WO2017073923A1 (en) Compound and color conversion film comprising same
WO2016085087A2 (en) (meth)acrylic compounds having high refractive index, preparation method therefor, optical sheet comprising same, and optical display device comprising same
WO2013051831A2 (en) Composition for forming an alignment layer, and alignment layer and phase difference film manufactured using same
WO2021010701A1 (en) Compound, photosensitive fluorescent resin composition comprising same, color conversion film manufactured therefrom, backlight unit, and display device
WO2014193072A1 (en) Optical film with excellent ultraviolet cut-off function and polarizing plate including same
WO2019093805A1 (en) Nitrogenous cyclic compound and color changing film comprising same
WO2022045838A1 (en) Method for preparing deuterated aromatic compound, and deuterated reactive composition
WO2018093121A1 (en) Nitrogen-containing compound and color conversion film comprising same
WO2019054707A1 (en) Novel triazine derivative and photosensitive composition comprising same
WO2015064958A1 (en) Novel oxime ester biphenyl compound, photo initiator and photosensitive resin composition containing same
WO2020080784A1 (en) Compound and color conversion film comprising same
WO2019216600A1 (en) Novel oxime ester compound and photoresist composition comprising same
WO2019212183A1 (en) Polymerizable liquid crystal compound, liquid crystal composition for optical element, polymer, optically anisotropic body, and optical element for display device
WO2021177650A1 (en) Compound and optical film comprising same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18856779

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020535948

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18856779

Country of ref document: EP

Kind code of ref document: A1